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Abstract 
 Dietary fiber provides numerous benefits to the health of both companion animals and 
humans including improved digestive health (increases stool weight and promotes normal 
laxation) and systemic health (promotes satiety and decreases incidences of obesity and type II 
diabetes). Novel dietary fibers often are evaluated for their ability to induce prebiotic effects. 
Prebiotics are defined as non-digestible food ingredients that, when consumed in sufficient 
amounts, are fermented and selectively stimulate the growth, activity, or both, of one or a limited 
number of microbial genera or species in the gut microbiota that ultimately benefits health of the 
host. Not all dietary fibers are the same in terms of their physico-chemical properties, which 
ultimately affects their fermentability. The overarching objectives of this thesis were to assess two 
novel dietary fiber sources, potato fiber (PF) and soluble corn fiber (SCF), for their inclusion in 
commercial dog diets, and ultimately, their prebiotic potential and implications for host health. 
 Specifically, PF and SCF were evaluated for their chemical composition, in vitro 
fermentability, in vivo characteristics (nutrient digestibility and fecal fermentation characteristics), 
and ability to change fecal microbiota concentrations. Previous research in our laboratory found 
that feeding graded concentrations of dietary PF to dogs elicited linear increases (P < 0.05) in fecal 
acetate, propionate, butyrate, and total short-chain fatty acids (SCFA) without causing detriments 
to nutrient digestibility. We investigated this further by studying the prebiotic potential of PF by 
analyzing the fecal microbiome. We predicted that our previous results on fecal fermentation 
characteristics would be associated with shifts in the fecal microbiome.  Based on previous studies 
involving dietary fiber in pets and humans, we expected that at the phylum level, an increase in 
fecal Firmicutes and a decrease in fecal Fusobacteria would occur. More specifically, we also 
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 predicted increases in bifidobacteria and other SCFA-producing genera (e.g., Blautia, 
Lachnospira, and Faecalibacterium spp.) with increasing dietary PF concentrations.  
As anticipated, with increasing concentrations of dietary PF, there were significant (P < 
0.05) changes in fecal concentrations of key SCFA-producing bacteria. Butyrate-producing 
genera, such as Blautia and Faecalibacterium spp. increased (P < 0.05) with increasing dietary PF 
concentrations, which was confirmed by qPCR. Our sequencing data also confirmed an increase 
(P < 0.05) in Firmicutes and a decrease in Fusobacteria (P < 0.05) with increased dietary PF 
consumption. Prebiotics often are evaluated by their ability to produce butyrate (a butyrogenic 
effect) or to stimulate the growth of bifidobacteria (a bifidogenic effect); however, the definition 
of a prebiotic is not limited to this genus. We found that with ingestion of PF, Bifidobacterium 
spp. were positively correlated with butyrate (R = 0.49; P < 0.05) and lactobacilli (R = 0.82; P < 
0.05) concentrations. Bifidobacteria’s main carbohydrate fermentation products are acetate and 
lactate when substrate is available, while lactobacilli produce lactic acid. This has previously been 
explained by bacterial cross-feeding where primary fermenters of carbohydrate will produce 
secondary metabolites (acetate and lactate) or hydrolyzed substrate that can be utilized by other 
bacteria. Overall, this research suggests to us that PF is beneficial to gut health and should be 
investigated as a novel functional ingredient in dog diets.   
 Soluble corn fiber (NUTRIOSE®) also was evaluated for its efficacy as a fiber source in 
dog foods; however, the objective was to determine a minimum dose to elicit a prebiotic effect. 
We found that SCF was highly fermentable in vitro showing increases (P < 0.05) in acetate, 
propionate, and butyrate concentrations over 12 h. When tested in vivo from 0-1.25% of the diet, 
we found no detrimental effects on nutrient digestibility or fecal consistency; however, no changes 
were shown in fecal fermentation characteristics. Furthermore, this translated into no appreciable 
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 differences in the fecal microbiome. Overall, SCF was fermentable in vitro; however, more 
research is needed to evaluate a more effective dose to elicit in vivo effects.  
 The changes we observed with increasing dietary PF in the dog presented the most 
intriguing results. Faecalibacterium, and more specifically, Faecalibacterium prausnitzii, a well-
characterized butyrate-producing species, was increased by feeding graded dietary levels of PF to 
dogs. This bacteria is often found in low concentrations in humans and dogs with inflammatory 
bowel diseases (IBD). These previous results led us to investigate whether PF, with its in vivo 
fermentation characteristics and ability to modulate the microbiome, would be efficacious in 
attenuating the inflammatory response in the dextran-sodium sulfate (DSS)-induced colitis mouse 
model. We hypothesized that a moderately fermentable PF would be more effective at attenuating 
the symptoms and inflammatory response in DSS colitis than non-fermentable cellulose (Cell). 
Mice provided the PF/DSS treatment exhibited decreased (P < 0.05) symptoms of DSS colitis by 
showing a delayed loss in body weight compared with mice provided the Cell/DSS treatment. 
Furthermore, fermentation of PF during DSS colitis was found to be anti-inflammatory by showing 
suppression (P < 0.05) of distal colon gene expression of inflammatory cytokines (TNF-α, IL-1β, 
IL-6, and IL-17A). 
 What was particularly interesting were the changes in distal colon gene expression of 
CXCL1, which is a neutrophil chemoattractant. Mice provided non-fermentable Cell had a 7-fold 
increase (P < 0.05) in CXCL1 expression compared with all other treatment groups. Pathology 
scores from an independent observer also showed decreases (P < 0.05) in leukocyte infiltration 
scores in distal colon.  In this acute-colitis model, neutrophils would be the predominant innate 
immune cell type at the site of inflammation. Therefore, this suggests that fermentation of PF to 
produce SCFA may be a driving force in controlling leukocyte recruitment to the site of 
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 inflammation. As a potential mechanism linking SCFA concentrations and leukocyte recruitment, 
we analyzed free fatty acid receptor 2 (FFAR2) expression in distal colon. Leukocytes, and in 
particular neutrophils, have FFAR2 on their cell surface. Short-chain fatty acids can bind to this 
receptor, causing changes in chemotaxis and reactive oxygen species concentrations. We found 
that DSS caused an increase (P < 0.05) in FFAR2 expression in distal colon; however, there was 
no main effect of diet or an interactive effect. One alternative mechanism proposed was the role 
of SCFA suppressing innate T-helper 17 (Th17) cells, which recruit neutrophils and monocytes 
through the concentrations of IL-17A and chemokines. Short-chain fatty acids have been found to 
induce both effector and regulatory T cells by suppression of histone deacetylases that is 
independent of FFAR2 or 3. Inhibition of histone deacetylases by SCFA and, in particular, acetate, 
has been shown to regulate the mTOR pathway required for the generation of Th17 cells. 
Collectively, these data show that moderately fermentable fiber intake during DSS colitis is anti-
inflammatory, which could potentially be due to SCFA decreasing leukocyte recruitment. 
 Overall, the ability of a dietary fiber to elicit positive effects on fermentation and health 
benefits is due to the physico-chemical properties of the fiber. Here, we found that ingestion of a 
moderately fermentable fiber elicited increases in fecal SCFA concentrations, and modulated the 
microbiome. This dietary fiber elicited anti-inflammatory effects in the DSS-model, which may 
have been a result of SCFA affecting leukocyte recruitment to the site of inflammation. These data 
show that ingestion of a moderately fermentable prebiotic fiber could affect the acute inflammatory 
response through controlling leukocyte recruitment. More studies are needed to assess the 
importance of moderately fermentable fibers in the diet during in controlling inflammatory bouts 
noted in IBD.  
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CHAPTER 1: LITERATURE REVIEW 
 Introduction 
The interest in dietary fiber improving health has increased with new insights about the 
beneficial effects of the gut microbiome and their fermentation end-products (i.e. short-chain fatty 
acids (SCFA)). The human colonic microbes and their metabolic end-products have been 
associated with diseases such as diabetes mellitus (Larsen et al., 2010) inflammatory bowel 
diseases (IBD), Crohn’s disease, and ulcerative colitis (Kranich et al., 2011), obesity (Turnbaugh 
et al., 2009), and others. Furthermore, companion animals also are subject to these diseases, 
making this area of research applicable to dogs and cats as well. The most apparent link between 
colonic microbial populations and their role in health and disease is SCFA concentrations and, in 
particular, concentrations of acetate, propionate, and butyrate (Ganapathy et al., 2013). Dietary 
fermentable fiber, resistant starch, and other indigestible carbohydrates are foods for the colonic 
microbes, which will, in turn, produce SCFA. The capacity of dietary fibers to produce SCFA is 
due to a number of factors including the physico-chemical properties of the fiber, as well as the 
resident microbial populations present in the colon. It is well established that dietary fiber is 
important in both companion animal and human diets to improve intestinal and host health. These 
health benefits include improved stool characteristics, ease of laxation, and modulation of the 
intestinal microbiota concentrations. Specifically understanding how dietary fermentable fiber and 
changes in the colonic microbiome relate to the health of the host could provide more insight about 
the beneficial effects of dietary fiber in both companion animal and human diets. Through the use 
of animal models and modern day techniques, it has become possible to integrate the quantification 
of microbial populations with products of their metabolism and, in turn, the effects of the 
microbiome on host immunity in both healthy and diseased states. The underlying objective of this 
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 thesis is to evaluate the efficacy of two novel fibers in the dog diet and how they change the 
microbiome. Furthermore, investigated how these changes relate to the health of the host using a 
mouse model.  
Dietary fiber 
 Dietary fiber is the edible part of plants or analogous carbohydrates resistant to digestion 
and absorption in the small intestine, with complete or partial fermentation in the large intestine 
(Prosky, 2000). It includes polysaccharides, oligosaccharides, lignin, and associated plant 
substances. Fiber is indigestible to mammalian enzymes due to the unique structural and chemical 
aspects of the plant cell wall and some cell contents, as well as β - glycosidic bonds between 
monosaccharide units that make fiber indigestible to mammalian enzymes (Buxton and Redfearn, 
1997). Pancreatic amylase and isomaltase hydrolyze only α-1,4 and α-1,6 glycosidic bonds found 
primarily in starches (Coombe and Siddons, 1973). Bacterial enzymes in the hindgut, such as β-
galactosidase, α-glucosidase, β-glucosidase, and β-glucuronidase, hydrolyze polysaccharides with 
β-glycosidic bonds (Tan et al., 2010). 
Potato fiber and soluble corn fiber 
Polysaccharides in the plant cell wall can be separated into two categories: soluble fiber, 
which may be viscous and highly fermentable, and insoluble fiber, which is generally non-viscous 
and partially- to non-fermentable. Potato fiber (PF) is a co-product of potato starch isolation that 
is widely used in the beef industry (Nelson, 2010). Briefly, potato starch processing involves 
rupturing the starch granules and subsequent gelatinization. The rupturing process disrupts the 
cells to free the starch granule (Nigam and Singh, 1995). This mash then is diluted and placed into 
a centrisieve to separate the skin and other cell contents from the starch. The skin and cell 
fragments are referred to as the pulp or the fiber component that makes up PF (Klingspohn et al., 
2 
 
 1993). The carbohydrate fractions of PF include pectins, resistant and digestible starch, cellulose, 
and hemicelluloses (Klingspohn et al., 1993). Potato fiber has the potential to be a high quality 
fiber source in pet foods due to its considerable amount of insoluble and soluble fiber, as well as 
its resistant starch content. Soluble fiber sources are thought to benefit gut health due their 
fermentability and modulation of the microbial ecology of the colon.  
Very little research has been conducted on the nutritional value of PF. Laerke et al. (2007) 
found that the soluble fiber fraction of PF resulted in higher rat cecal SCFA concentrations of 
173.5 µmole compared to 83.0 µmoles for cellulose controls.  Furthermore, solubilized PF 
decreased postprandial plasma triacylglycerol from 2.79 mmol/L in the cellulose control diet to 
1.82 mmol/L in the solubilized PF diet. Human data showed that consumption of enzymatically-
solubilized potato fibers induced a 200% increase in breath H2 analysis compared to oat bran, 
which was interpreted as increased fermentation (Olesen et al. 1998). Thomassen et al. (2010) 
solubilized potato pulp and conducted an in vitro fermentation study with human fecal inoculum 
to evaluate prebiotic effects. Solubilized potato pulp was three times more bifidogenic than FOS 
by showing a 300% increase in fecal Bifidobacterium spp. DNA concentrations compared with 
FOS.  Furthermore, it was concluded that soluble fiber fractions of greater than 100 kDa had the 
greatest effect. These studies focused on the soluble fiber fractions of potato pulp, but they did not 
evaluate potato pulp in its native form that contains significant amounts of both insoluble and 
soluble fibers. Furthermore, the application of potato pulp as a dietary fiber source in high quality 
dog foods has not been investigated.   
Another fiber source more commonly found in the human food industry is soluble corn 
fiber (NUTRIOSE®FM). NUTRIOSE is a soluble fiber that is produced from the dextrinization 
of corn, tapioca, or wheat starch. It is a glucose polymer (degree of polymerization 12-25) of mixed 
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 beta and some alpha linkages (Pouillart et al., 2010). Soluble corn fiber is a novel, low digestible 
carbohydrate derived from hydrolysis of corn starch by heat and acid. Upon cooling, reformation 
of mixed β-glycosidic linkages resistant to mammalian enzymatic hydrolysis occurs. Soluble corn 
fiber is commonly used in the human food industry to aid in colonic health and as a low glycemic 
food additive (Knapp et al., 2010). Previous research found it to be fermentable and have positive 
effects on changing the colonic microbiome of humans and rats; however, there is limited research 
on its use in dog foods. The previous in vivo studies in humans and rodents have shown the 
potential health benefits of SCF as a fiber source at higher dietary concentrations. Dietary SCF 
concentrations of 5% or higher in rats have been found to improve cecal and colonic fermentation 
characteristics, as well as indices of gut health (i.e., increased crypt depth, goblet cell numbers, 
and acidic mucins) (Guerin-Deremaux et al., 2010; Knapp et al., 2013). Similarly, in humans, 
consumption of SCF at 20 g/d resulted in a decrease in colonic pH, suggesting increased 
fermentative activity (Lefranc-Millot et al., 2012). 
 In our laboratory, both PF and SCF have been investigated for their chemical composition, 
in vitro fermentability, as well as in vivo effects on nutrient digestibility, fecal consistency and 
fermentability (Panasevich et al., 2013; Panasevich et al. 2015). Dietary fiber sources act 
differently within the colon depending on chemical composition and the resident microbial 
populations and their metabolic capabilities. Panasevich et al. (2013) evaluated PF for its chemical 
composition and 12 h in vitro fermentation, and in vivo effects on nutrient digestibility, fecal 
fermentation end-products, and fecal consistency. This study revealed that PF contained 55% TDF 
with 32% insoluble fiber and 23% soluble fiber. Along with having relatively high amounts of 
TDF, PF also contained digestible starch and resistant starch, along with low amounts of crude 
protein, free sugars, and acid hydrolyzed starch. This translated into favorable effects in a 12 h in 
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 vitro fermentation by showing increases in acetate, propionate, and butyrate concentrations 
through 9 h (Panasevich et al., 2013). 
The in vivo experiment revealed that dogs ingesting graded concentrations of PF up to 6% 
exhibited linear increases in fecal acetate, propionate, butyrate, and total SCFA. It was concluded 
from both in vitro and in vivo data that PF is a moderately fermentable fiber that could be a 
functional ingredient in commercial dog food. Like PF, our lab also evaluated SCF for its chemical 
composition, 12 h in vitro fermentation, in vivo effects on nutrient digestibility, and fecal 
fermentation characteristics and consistency in dogs (Panasevich et al., 2015). The SCF substrate 
had 23% TDF, with a majority of that portion being low molecular weight soluble fiber (degree of 
polymerization greater than 3 and less than 10). The substrate also had high concentrations of free 
glucose. The 12 h in vitro fermentation indicated that SCF was more fermentable than cellulose, 
but less fermentable than pectin. Overall, SCF resulted in increased concentrations of acetate, 
propionate, and butyrate throughout the in vitro experiment. 
The in vivo experiment with SCF did not show the anticipated results as indicated from the 
in vitro experiment. The objective of the in vivo experiment was to determine the lowest 
concentration of NU in the diet that will elicit increases in fecal SCFA and prebiotic effects. With 
increasing concentrations of NU in the diet up to 1.25%, no changes in nutrient digestibility or 
fecal SCFA concentrations were noted. The in vitro experiment suggested that SCF would be 
highly fermentable in vivo in the dog. It was concluded that the amount of SCF could have been 
too low to elicit changes in fermentability. 
The colonic microbiota 
 The gut microbiome is involved in a symbiotic relationship with the host and influences 
host health (Kamada et al., 2013). It has been estimated that there are over a thousand different 
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 species of bacteria that have numerous implications on host health and disease (Hooper and 
Gordon, 2001). A principal function of the commensal microbiota is to protect against invasion of 
pathogens into the colon (Buffie and Pamer, 2013). These pathogens will compete for nutrients 
with the resident microbes and disrupt the normal microbiota populations that can have a negative 
effect on the immune system (Kamada et al., 2013). The colonic microbiome has been found to 
have an effect in acute and chronic inflammatory diseases such as inflammatory bowel diseases 
(IBD), Crohn’s disease, ulcerative colitis, and obesity (Guinane and Cotter, 2013; Turnbaugh et 
al., 2009). Furthermore, modulation of the microbiome through nutrition has grown interest in 
helping to manage these diseases.  
The canine fecal microbiota 
 The canine gut microbiota has been characterized and reviewed extensively in both the pre 
sequencing and sequencing eras (Hooda et al., 2012). The predominant genera of bacteria that have 
been cultured from the large intestine of dogs include Bifidobacterium, Bacteroides, 
Fusobacterium, Peptostreptococcus, Eubacterium, Clostridium, Peptococcus, and Lactobacillus 
(Davis et al., 1977). Middelbos et al., (2010), was the first to use 16S rRNA gene pyrosequencing 
to characterize the healthy canine fecal microbiome. Results from this study indicated that the 
predominant phyla included Firmicutes (15-28%), Bacteroidetes (32-34%), Fusobacteria (24-
40%), Actinobacteria (0.8 – 1.4%), and Proteobacteria (5-6%) (Middelbos et al., 2010). Overall, 
this suggested that the canine feces mainly consist of Firmicutes, Bacteroides, and Fusobacteria; 
however, shotgun sequencing identified the same phyla only in difference in abundance 
(Bacteroides and Firmicutes, ~35%; Fusobacteria, 7-8%) (Swanson et al., 2011).  
 Amplification of the variable regions (V) 1 – V3 found the most abundant bacterial families 
include Ruminococcaceae, Clostridiaceae, Lachnospiraceae, and Erysipelotrichaceae (Handl et al., 
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 2011; Garcia-Mazcorro et al., 2011). Within the clostridia class, Clostridium, Ruminococcus, 
Dorea, and Roseburia are prevalent genera in dog feces. Furthermore, within Clostridium, clusters 
XIVa and XI were most dominant and have been linked to GI health outcomes by their role in 
concentrations of SCFA (Hooda et al., 2012).  
 Amplification of 16S rRNA gene pyrosequencing has provided a more comprehensive 
understanding of the dog fecal microbiota populations. Some inconsistencies exist with past 
studies however, due to DNA extraction methods and primer biases that result in over or under 
representation of some microbial genera (Hooda et al., 2012). Along with characterizing the 
microbiota populations, it is equally important to also establish the metabolic capabilities of the 
microbiota. Swanson et al., (2011) reported that the primary functional categories of the fecal 
microbiota in healthy dogs include associations with carbohydrate metabolism (12.5-13% of total 
sequences), protein metabolism (8.1-9.1%), DNA metabolism (7.1-7.4%), cell wall and capsule 
(7.0-7.6%), amino acids and derivatives (6.8-6.9), virulence (6.2-7.2%), and cofactors, vitamins, 
prosthetic groups and pigments (5.7-6.0%). Understanding microbial dysbiosis and host-microbe 
interactions is important in characterizing pathogenesis of diseases. For instance, a recent study 
compared the fecal microbiota and serum metabolite profiles between healthy dogs and dogs with 
inflammatory bowel disease (IBD) before and after 3 weeks of medical therapy (Minamoto et al., 
2015). Specifically, dogs with IBD exhibited lower bacterial diversity and higher amounts of 
Gammproteobacteria and revealed overrepresentation of bacterial secretion system and 
underrepresentation of amino acid metabolism (Minamoto et al., 2015). Overall, this reveals the 
importance of understanding both the microbial populations and their implications to host health. 
The microbiome and inflammatory bowel disease 
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  Inflammatory bowel disease includes both Crohn’s disease and ulcerative colitis. Overall, 
IBD is an economic burden in the United States. In 2008, direct treatment costs for patients with 
IBD were estimated to be greater than $6.3 billion and indirect costs, such as missed work 
opportunities, estimated to cost an additional $5.5 billion (Center for Disease Control, 2012). 
Currently, there is no cure, and the disease requires constant pharmacological management (Center 
for Disease Control, 2012). Recently, more research is focused on investigating the role of the 
colonic microbiota in the pathogenesis of IBD. With new insights into microbial populations and 
their metabolic implications through the use of next-generation high-throughput sequencing 
techniques, we can more accurately assess the role of the microbes in the pathogenesis of IBD. In 
general, IBD patients are thought to maintain a diverse colonic microbiota, but evidence suggests 
that Crohn’s disease patients may have higher proportions of Enterobacteria compared to healthy 
controls, with up to 30% of their dominant microbiome belonging to undefined phylogenetic 
groups (Seksik et al., 2003). However, the microbial populations of these two diseases are quite 
different (Bibiloni et al., 2006). Specifically, Crohn’s disease patients had higher proportions of 
unclassified members of Bacteroides than ulcerative colitis patients (Bibiloni et al., 2006).  
 More recent studies have identified specific microbial genera and species that are involved 
in IBD. Patients with IBD tend to have a microbiome that is more indicative of proteolytic 
fermentation and less carbohydrate fermentation. Specifically, IBD patients tend to have higher 
fecal gamma-proteobacteria (Li et al., 2012), Enterobacteraceae (Garrett et al., 2010) and 
Clostridium spp. and lower Firmicutes, Bacteroidetes (Frank et al., 2007), SCFA-producing super-
family Lachnospiracheae, Faecalibacterium (F.prausnitzii), Roseburia, and 
Phascolarctobacterium (Li et al., 2012; Guinane et al., 2013). Similarly, dogs with idiopathic 
inflammatory bowel disease and acute diarrhea have lower proportions of fecal Blautia and 
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 Faecalibacterium compared to healthy dogs (Suchodolski et al., 2012). Honneffer at al. (2014) 
reviewed intestinal dysbiosis in dogs and cats and compared human IBD with IBD in dogs and 
cats. Specifically compared with the dog, humans with IBD show similar shifts of dysbiosis by 
exhibiting lower Firmicutes, Ruminococcaceae, and Lachnospiraceae.  Collectively, these results 
give insight into the potential role that nutrition and, in particular, dietary fermentable fiber could 
help to control the inflammatory response through modulation of the microbiome.  
 Ingestion of fermentable fibers can modulate the microbiome that may be favorable in 
suppressing inflammation in IBD in humans and companion animals. Having diversity within the 
bacterial phylum, Firmicutes, is suggests increased SCFA concentrations and an overall reduced 
risk of certain bowel diseases (Hooda et al., 2012; Li et al., 2012; Frank et al., 2007). Specifically 
in humans, ingestion of fermentable polydextrose and soluble corn fiber has been found to increase 
Faecalibacterium and, in particular, F. prausnitzii, a known butyrate producer (Hooda et al., 
2012). Similarly in healthy dogs, there was an increase in Faecalibacterium and, in particular, F. 
prausnitzii, with increased concentrations of dietary potato fiber (Panasevich et al., 2015). In dogs 
and humans, low concentrations of Faecalibacterium have been associated with acute and non-
hemorrhagic diarrhea and poor gut health (Suchodolski et al., 2012; Sokol et al., 2008).  The 
presence of F. prausnitzii in the hindgut has been associated with suppressing the onset of Crohn’s 
disease in humans (Sokol et al., 2008). These results have suggested F. prausnitzii as a potential 
probiotic for the suppression of Crohn’s disease (Hooda et al., 2012; Sokol et al., 2008) and IBD 
prevention in general (Hooda et al., 2012). 
Prebiotics 
 Prebiotics are a common food additive in the human food industry and are increasingly 
popular in companion animal diets. Prebiotics are defined as non-digestible food ingredients that, 
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 when consumed in sufficient amounts, selectively stimulate the growth, activity, or both, of one 
or a limited number of microbial genera or species in the colonic microbiota that ultimately 
benefits health of the host (Tremaroli and Backhed, 2012). Ingestion of a substrate by the host, 
such as a soluble fiber, could be used by bacteria like Bifidobacterium and Lactobacillus spp. to 
promote growth of their numbers while simultaneously decreasing harmful bacteria like 
Clostridium perfringens and Escherichia coli. Common prebiotics used in human foods also are 
frequently used in pet foods and include inulin, and fructooligosaccharides (FOS) (Tomasik and 
Tomasik, 2003). Certain prebiotic fibers can influence the colonic microbiota differently by their 
selectively influencing certain genera or species of bacteria. For example, inulin and trans– 
galactooligosaccharides both are considered bifidogenic prebiotics due to their ability to 
selectively stimulate the growth of bifidobacteria. (Roberfroid et al., 2010). Chicory root, 
artichokes, garlic, onion, bananas, rye, wheat, oats, and soybean are other common sources of 
naturally-occurring prebiotic oligosaccharides (Yen, 2003). 
Potato fiber and SCF also were evaluated for their prebiotic potential (Panasevich et al. 
2014; Panasevich et al. 2015). The increased concentrations in fecal SCFA when dogs were fed 
graded levels of dietary PF corresponded with what was noticed in the fecal microbiome. With 
increasing concentrations of PF in the diet, dogs exhibited linear increases in SCFA-producing 
bacteria at the genus and species levels. Faecalibacterium, and specifically F. prausnitzii, 
increased in dog feces when dogs were fed graded concentrations of PF. Clostridium, and in 
particular C. hiranonis, was lowest when dogs were fed 6% PF. C. hiranonis has been known to 
be involved in 7α-dehydroxylation activity, which results in 7α-dehydroxylation of primary and 
secondary bile salts (Kitahara et al., 2001). Secondary bile salts have been associated with an 
increased risk of colon cancer in humans (Reddy et al., 1996). 
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   Other microbial genera and species in the Lachnospiraceae family, which is a known 
SCFA-producing bacterial family, increased with PF intake. In humans, ingestion of prebiotics has 
been found beneficial in the inflammatory bowel diseases, Crohn’s and ulcerative colitis. 
Specifically, males ingesting polydextrose had increases in fecal SCFA with concomitant increases 
in Faecalibacterium prausnitzii, which is a butyrate producer found in lower concentrations in 
patients with Crohn’s disease (Hooda et al., 2012).  Similarly, dogs with idiopathic inflammatory 
bowel disease and acute diarrhea have lower proportions of fecal Blautia and Faecalibacterium 
compared to healthy dogs (Suchodolski et al., 2012). Soluble corn fiber also was evaluated for 
prebiotic effects but overall, there was very little modulation of the microbiome. Our lab concluded 
that SCF maintained the resident microbial populations. Overall, an increase in Faecalibacterium 
and a decrease in Clostridium genera with increasing concentrations of PF are believed to be 
beneficial to gut health. These results agreed with the fermentation characteristics reported by 
Panasevich et al. (2013).   
After evaluation of both PF and SCF, it is clear that different dietary fibers act differently 
within the gastrointestinal tract. The degree of fermentability is due to the chemical composition 
of the substrate, the amount of that substrate entering the large bowel, and the resident microbes 
ability to ferment the substrate. Recently, there is growing interest in how changes in the colonic 
microbiome can influence health of the host. Ingestion of dietary PF elicited increases in SCFA 
concentrations, as well as beneficial changes in the fecal microbiome in the dog. More research is 
needed in finding how the PF substrate could affect host health through modulation of the 
microbiome and concentrations of SCFA.    
The inflammatory response 
Chronic inflammation 
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  The chronic inflammatory response is characterized as a prolonged duration (weeks to 
years) of continuing inflammation, tissue injury, and healing, often fibrosis, and proceeding 
simultaneously (Robbins basic pathology) (Kumar et al., 2013). Different sets of reactions define 
the chronic inflammatory response as opposed to the acute inflammatory response. The three main 
steps of mounting chronic inflammation include infiltration of mononuclear cells, including 
plasma cells, lymphocytes, and macrophages, tissue destruction by products of inflammatory cells, 
and repair (Kumar et al., 2013). Acute inflammation could lead to chronic inflammation if 
unresolved. The most dominant cells of chronic inflammation are macrophages, which are together 
classified as the mononuclear phagocyte system. Two subsets of macrophages are involved in 
inflammation and then anti-inflammation. Classical activation involves macrophage type 1, which 
produce lysosomal enzymes, nitric oxide, and reactive oxygen species to kill a foreign antigen. 
Alternative activation involves macrophage type 2 that, in turn, is anti-inflammatory (Kumar et 
al., 2013). These macrophage types are induced by interleukin (IL)-4 and IL-13, which are 
cytokines produced by T lymphocytes, mast cells, and eosinophils, to help with tissue repair.  
 Lymphocytes also are major drivers in mounting the chronic inflammatory response.  Both 
T and B lymphocytes will migrate to inflammatory sites and recruit other leukocytes (Kumar et 
al., 2013). Development of cluster of differentiation (CD) 4+ T lymphocytes will secrete cytokines 
and influence the nature of the inflammatory status, while B lymphocytes will transition to plasma 
cells that secrete antibodies to the infection. There are subsets of CD4+ helper T cells that promote 
different types of inflammation. T-helper 1 (TH1) activate macrophage type 1 cell types to promote 
inflammation and produce interferon-gamma (IFNγ). T-helper-2 (TH2) cells recruit and activate 
eosinophils and secrete IL-4, IL-13, and IL-5. Macrophage type 2 are activated by TH2 to promote 
tissue repair. T-helper 17 (TH17) recruit neutrophils and monocytes into the site of inflammation 
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 through secretion of IL-17 and other chemokines (Kumar et al., 2013). Eosinophils and mast cells 
are also involved in chronic inflammatory responses by secreting cytokines and present antibodies 
to combat infections (Kumar et al., 2013).  
Acute inflammation 
 The acute inflammatory response is defined as the rapid delivery of leukocytes and plasma 
proteins to the site of inflammation/injury (Kumar et al., 2013). The recruited leukocytes will begin 
to digest and remove necrotic tissue. The two major components of the acute inflammatory 
response include vascular and cellular changes. The onset of inflammation will promote 
vasodilation, vascular permeability to permit plasma proteins to leave circulation, and endothelial 
signaling to result in increased adhesion and migration of leukocytes (Kumar et al., 2013). Cellular 
recruitment of leukocytes allows for the first defense to a foreign antigen. Neutrophils, also 
referred to as polymorphonuclear cells, are the principal cell types to initiate the inflammatory 
response and are considered the first responders to the site of injury (Kumar et al., 2013).  
 The recruitment of leukocytes to the site of inflammation in an acute injury include 
margination and rolling, adhesion to the endothelium, transmigration between endothelial cells, 
and migration in interstitial tissues towards a chemoattractant. A series of lectins, selectins, and 
integrins on endothelial cells and leukocytes mediate the rolling, adhesion, and transmigration 
processes. These leukocyte and endothelial molecules are expressed more during an inflammatory 
insult and are critical in leukocyte recruitment. After extravasating from the blood, leukocytes will 
migrate toward a site of inflammation along a chemical gradient in a process called chemotaxis. 
There are a number of exogenous and endogenous chemoattractants for leukocytes including 
cytokines/chemokines, leukotriene B4, bacterial peptides with N-formylmethionine termini, and, 
more recently, SCFA (in the case of neutrophils) (Kumar et al., 2013).  
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  The cell types that are recruited in an acute inflammatory response depend on the duration 
of inflammation. Neutrophils are the first responders to the site of inflammation (first 6 to 24 hours) 
and then are replaced by monocytes (24 to 48 hours) (Kumar et al., 2013). After two days, 
monocytes and macrophages will begin to be active in the inflammatory response. After being 
recruited to the site of inflammation, leukocytes will be activated to destroy the foreign substance. 
They phagocytize particles and destroy microbes and dead cells within the phagosome by 
producing reactive oxygen species, lysosomal enzymes, and nitrogen species (Kumar et al., 2013). 
Neutrophils also will create extracellular traps that can destroy extracellular microbes and dead 
cells, as well as recruit other leukocytes to amplify the inflammatory response (Kumar et al., 2013). 
Dextran sodium sulfate (DSS)-induced colitis 
 The most widely used mouse model for colitis research uses DSS dissolved in the rodent’s 
water (Chassaing et al., 2014). It is a water-soluble, poly-anionic, sulfated compound that has a 
highly variable molecular weight (5-1400 kDa). The most effective way of inducing colitis is 
administration of 40-50 kDa DSS into drinking water. The mechanism by which DSS induces 
colitis is unclear; however, one underlying mechanism is that it causes damage to the epithelial 
monolayer in the large bowel, making the gut more penetrable to the microbiota and intestinal 
contents. Some of the major advantages of the DSS-rodent model is that it is rapidly induced, easy 
to control, reproducible, and simple to prepare. In IBD, there are intermittent bouts of 
inflammation, which can be easily achieved by modifying the concentration and frequency at 
which DSS is provided.  
 One of the major pitfalls to DSS colitis is that it does not require a T or B cell response in 
order to cause inflammation (Chassaing et al., 2014). Therefore, the model is best when used to 
study the innate immune response. Despite this shortcoming, DSS has offered the most reliable 
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 simulation of ulcerative colitis in humans. Ulcerative colitis is driven more by a Th2 response by 
showing resulting in concentrations of IL-4, IL-10, IL-5, and IL-13. It has been shown in a chronic 
colitis model of DSS (multiple longer bouts of DSS) that IL-4 secretion is upregulated (Stevceva 
et al., 2001). Furthermore, IL-12 knockout mouse models have been found to be protective against 
DSS colitis, whereas IL-18 knockouts have an exacerbated inflammatory response to DSS (Takagi 
et al., 2003). Both IL-12 and IL-18 strongly induce interferon-gamma (IFN-γ), and IL-18 and IL-
2 in combination induce IL-4, which is a strong Th2 cytokine (Dinarello, 1999; Yoshimoto et al., 
1999; Hoshino et al., 2000). 
Dietary fiber and DSS colitis 
 Diet has been known to affect the severity of IBD. In particular, diets high in total fat, 
omega-6 fatty acids, meat, and total polyunsaturated fatty acids have been associated with 
increased risk of ulcerative colitis (Hou et al., 2011). Evidence from a DSS-induced colitis rat 
model suggested a variety of bacteria (e.g., Bacteroides spp. and others) may be involved in 
initiating the underlying inflammatory response (Seksik et al., 2003). Dietary fiber is a nutrient of 
interest in controlling the inflammatory response in IBD. Previous studies testing prebiotic fibers 
in DSS-colitis rodent models have typically elicited anti-inflammatory effects. Ingestion of dietary 
fibers such as rice bran, resistant starch, and hydrolyzed plant polysaccharide (Ambrotose® 
Complex and Advanced Ambrotose® Complex) were found to reduce mucosal damage and have 
anti-inflammatory properties (Komiyama et al., 2011; Moreau et al., 2003; Naito et al., 2006). 
Conversely, dietary flaxseed, which contains anti-inflammatory bioactive components such as 
fermentable fiber, phenolic compounds, and the polyunsaturated fatty acid, α-linolenic acid, was 
found to exacerbate colonic damage and inflammatory cytokines even with increases in cecal 
SCFA concentrations (Zarepor et al., 2014). Consumption of highly fermentable FOS also has 
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 produced mixed results in reducing DSS-induced colonic damage (Winkler et al., 2007; Goto et 
al., 2010). A study investigating the fiber enriched vs. low-fiber germinated barley foodstuff in 
DSS-colitis found that the fiber component was anti-inflammatory (Kanauchi et al., 2001). 
Collectively, these studies suggest that moderately fermentable and butyrogenic dietary fibers are 
the most effective at attenuating DSS-colitis. 
Dietary fiber and other models of colitis 
 Research involving dietary fermentable fiber and control of the inflammatory response has 
been shown mainly in mice, rats, and guinea pigs. Rats induced with trinitrobenzenesulfonic acid 
(TNBS) colitis and given a resistant starch diet were found to have less sickness behavior and 
increased proliferation of intestinal epithelium compared with rats fed no resistant starch 
(Jacobasch et al., 1999). Similarly, rats induced with TNBS colitis and fed 5% Plantago ovata 
seeds had decreases in myeloperoxidase (MPO) and nitric oxide activities, as well as a reduction 
in colonic tumor necrosis factor-alpha (TNF-α) compared to rats fed no fiber (Rodriguez-Cabezas 
et al., 2002). Another study in a more translational model to humans suggests that TNBS-induced 
colitis pigs ingesting soluble fiber dextran had a decreased inflammatory response, more beneficial 
microbiota (Peptostreptococcus and Bifidobacterium), and less weight loss compared to a no fiber 
group (Pouillart et al., 2010). Collectively, this suggests that with ingestion of dietary fermentable 
fiber and the concentrations of SCFA, the inflammatory response could be lessened in IBD. 
However, it is still crucial to elucidate the mechanisms that integrate dietary fermentable fiber 
modulating the microbiome that is indicative of SCFA concentrations and, specifically, how that 
could control inflammation.   
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 Short-chain fatty acids and inflammation 
 The mechanisms by which dietary fermentable fiber could control inflammation are 
complex. The link between microbial metabolism and host health is mostly attributed to SCFA 
concentrations (Ganapathy et al., 2013). The inflammatory response is induced in a number of 
chronic physiological conditions such as kidney disease, IBD, diabetes mellitus, and obesity. 
Consumption of diets low in fiber and high in refined carbohydrates has been found to increase 
plasma pro-inflammatory markers IL-6, TNF-α, and IL-18, even in otherwise healthy individuals 
(Giugliano et al., 2006). Dietary fiber has been found to decrease the inflammatory response in 
diseases such as chronic kidney disease, diabetes mellitus, and obesity (Fujii et al., 2013; Slavin, 
2005). One of the mechanisms that could explain a decrease in the inflammatory response is the 
role of microbial-derived SCFA in controlling the inflammatory response. 
 The three main SCFA produced in the colon from carbohydrate fermentation are acetate, 
propionate, and butyrate. The concentration of these compounds varies over the length of the 
gastrointestinal tract. Generally speaking, the proximal colon has a higher concentration of SCFA 
(70 to 140 mM) in all mammalian species due to greater availability of carbohydrate substrates 
compared with the distal colon (20 to 70 mM) where most of the carbohydrates have already been 
fermented (Slavin, 2005). In terms of inflammation and overall gut health, butyrate has been found 
to be the most beneficial in controlling intestinal inflammation. It is the preferred energy source 
for colonocytes, with only low concentrations of butyrate available to the liver. In dogs and 
humans, butyrate spares colonic oxidation of glucose and glutamine that can be used for energy in 
other tissues (Beaulieu et al., 2002; Topping et al., 2001). Evidence from recent cell culture studies 
investigating IBD and SCFA suggests butyrate reduces the inflammatory response by modulating 
antioxidant signaling pathways. Specifically, butyrate has been found to decrease inflammation 
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 through inhibition of nuclear factor kappa-B (NFκB) (Segain et al., 2000; Russo et al., 2012), a 
master regulatory switch closely involved in inflammatory processes, and increased PPARγ in 
colonic epithelial cells (Kinoshita et al., 2002). Recently, there has been interest in how SCFA 
control inflammation through signaling leukocytes to the site of inflammation.   
Short-chain fatty acids controlling leukocyte recruitment 
 One of the mechanisms by which dietary fermentable fiber could control the inflammatory 
response is through recruitment of leukocytes to the site of inflammation (Vinolo et al., 2009). 
Neutrophils, macrophages, CD4+T lymphocytes, and monocytes are at the forefront of this 
recruitment effort as each of these cells plays a critical role in the innate immune response. The 
colon is a primary site where foreign pathogens can gain access to systemic circulation via 
endothelial cells. Prevailing hypotheses suggest SCFA produced by the colonic microbiome could 
control leukocyte recruitment by two main mechanisms: (1) activation of G-protein coupled 
receptors (GPR41 and 43) or free fatty acid receptors 3 and 2 (FFAR3 and FFAR2), and (2) 
inhibition of histone deacetylase (Vinolo et al., 2011).  
 The acute inflammatory response recruits leukocytes to the site of inflammation in a multi-
step process that involves concentrations of chemokines and activation of adhesion molecules that 
interact with endothelial cells (Vinolo et al., 2011). The concentrations of SCFA may modify the 
recruitment of leukocytes to the inflammatory site; however, this was more pronounced in vitro 
than in vivo (Vinolo et al., 2009; Vinolo et al., 2011). The in vivo study in rats indicated that oral 
administration of the pro-drug of butyrate, tributyrin, reduced migration of leukocytes to the 
peritoneum in response to an inflammatory stimulus (Vinolo et al., 2011). The differences between 
in vitro and in vivo responses could be explained, in part, by the different properties of SCFA to 
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 induce cell migration and decrease concentrations of pro-inflammatory cytokines by other immune 
cell types (i.e. macrophages) (Vinolo et al., 2009; Le Poul et al., 2003; Park et al., 2007).  
 Neutrophil recruitment to the site of inflammation has been of recent interest in terms of 
controlling the inflammatory response. Specifically, SCFA have been found to bind members of 
the FFAR2 family, which are highly expressed on neutrophils, monocytes, and adipocytes. Since 
SCFA are binding agonists for FFAR2, they serve to activate several intracellular pathways such 
as protein kinase C, mitogen-activated protein kinases (MAPKs), and other transcriptional factors 
involved with the chemotactic movement of neutrophils (Vinolo et al., 2011). Although SCFA are 
a chemoattractant for neutrophils in vitro, there are limited studies that investigate their in vivo 
effects, as well as the effects of a SCFA/FFAR2 chemotactic interaction in the presence of other 
agonists such as formyl-methionine-leucine-phenylalanine, chemokines, and leukotriene B4 
(Vinolo et al., 2011). Recent evidence from a DSS-colitis-induced model involving FFAR2-
knockout mice suggested that ingestion of solubilized acetate in the presence of colonic microbiota 
ameliorated the acute inflammatory response (Maslowski et al., 2009). Furthermore, the ingestion 
of SCFA also had a systemic effect on inflammation by reducing inflammation in mice with 
asthma (Maslowski et al., 2009). The in vitro and in vivo studies clearly show an effect of SCFA 
on mounting a neutrophil chemotactic response; however, these results imply ingestion of SCFA, 
not intake of dietary fermentable fiber with subsequent concentrations of SCFA by the gut 
microbiota. 
 Research involving dietary fermentable fiber and control of the inflammatory response has 
been shown mainly in mice, rats, and guinea pigs. Rats induced with trinitrobenzenesulfonic acid 
(TNBS) colitis and given a resistant starch diet were found to have improved sickness behavior 
and increased proliferation of intestinal epithelium compared with rats fed no resistant starch 
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 (Jacobasch et al., 1999). Similarly, rats induced with TNBS colitis and fed 5% dietary fiber had 
decreases in MPO and nitric oxide activities, as well as a reduction in colonic TNF-alpha compared 
to rats fed no fiber (Rodriguez-Cabezas et al., 2002). Another study in a more translational model 
suggest that TNBS-induced colitis pigs ingesting soluble fiber dextran had a decreased 
inflammatory response, more beneficial microbiota, and less weight loss compared to a no fiber 
group (Pouillart et al., 2010). Collectively, this suggests that with ingestion of dietary fermentable 
fiber and the concentrations of SCFA, the inflammatory response could be protective in IBD. 
However, it is still crucial to elucidate the mechanisms of how prebiotic effects of certain dietary 
fibers change immune cell recruitment through increased concentrations of SCFA.  
Conclusions 
 Dietary fiber is important in both companion animal and human health. In particular, 
dietary fermentable fiber has been found to be beneficial in suppressing inflammatory diseases 
such as IBD and obesity. The anti-inflammatory effects of dietary fermentable fiber are attributed 
to beneficial shifts in the colonic microbiome that promote the increased concentrations of SCFA. 
With new high-throughput sequencing and analytical techniques, the fields of metagenomics and 
metabolomics are able to be combined to enable a more thorough understanding of how the 
microbiome can be altered via dietary fermentable fiber to ultimately benefit systemic health of 
both companion animals and humans.  
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 CHAPTER 2: MODULATION OF THE FECAL MICROBIOME OF HEALTHY ADULT 
DOGS BY INCLUSION OF POTATO FIBER IN THE DIET1 
Abstract 
 Inclusion of fermentable fibers in the diet can impact the hindgut microbiome and provide 
numerous health benefits to the host. Potato fiber (PF), a co-product of potato starch isolation, has 
a favorable chemical composition of pectins, resistant and digestible starch, cellulose, and 
hemicelluloses. The objective of this study was to evaluate the effect of increasing dietary PF 
concentrations on the fecal microbiome of healthy adult dogs. Fresh fecal samples were collected 
from ten female dogs with hound bloodlines (6.13 ± 0.17 yr; 22.0 ± 2.1 kg) fed five test diets 
containing graded concentrations of PF (0, 1.5, 3, 4.5, or 6% as-fed; Roquette Frères, Lestrem, 
France) in a replicated 5 x 5 Latin square design. Extraction of DNA was followed by amplification 
of the V4-V6 variable region of the 16S rRNA gene using barcoded primers. Sequences were 
classified into taxonomic levels using BLASTn against a curated GreenGenes database. Inclusion 
of PF increased (P < 0.05) fecal proportions of Firmicutes, while Fusobacteria decreased (P < 
0.05). Similar shifts were noted at the genus level and were confirmed by qPCR analysis.  With 
increasing concentrations of PF, fecal Faecalibacterium increased (P < 0.05). Post-hoc Pearson’s 
correlative analysis showed positive (P < 0.05) correlations with Bifidobacterium spp. and butyrate 
concentrations and Lactobacillus spp.  
 
 
   
1 Panasevich, M. R., K. R. Kerr, R. N. Dilger, G. C. Fahey, Jr., L. Guérin-Deremaux, G. L.  
Lynch, D. Wils, S. E. Dowd, and K. S. Swanson. 2014. Modulation of the faecal 
microbiome of healthy adult dogs by inclusion of potato fibre in the diet. Br. J. Nutr. 
113: 125-133. 
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 Overall, increases in Faecalibacterium (not Lactobacillus/Bifidobacterium; as confirmed by qPCR 
analysis) with increasing dietary PF along with increasing fecal short-chain fatty acid 
concentrations suggests that PF is a possible prebiotic fiber.   
Introduction 
The gastrointestinal tract of humans and animals is occupied with a dense and diverse population 
of bacteria that are known to influence health of the host. Changes in the host’s microbiome are 
affected by a number of factors including genetics, age, geographic location, and especially 
diet (Khachatryan et al., 2008; Mariat et al., 2009; Yatsunenko et al., 2012; Hooda et al., 2012). In 
particular, fermentable fibers have been known to favorably modulate the hindgut microbiome of 
both humans and animals (Hooda et al., 2012; Middelbos et al., 2010). However, the effects of 
dietary inclusion of graded concentrations of fermentable dietary potato fiber on the hindgut 
microbiome have not been investigated.  
Potato fiber is a co-product of potato starch manufacture with potential to beneficially 
modulate the hindgut microbiome. It is high in fibers such as hemicelluloses, cellulose, and pectin, 
and non-fiber components such as starch, oligopeptides, and free amino acids (Mayer, 1998). The 
monomeric composition of destarched PF consists mainly of galactose, galacturonic acid, 
arabinose, and rhamnose, which indicates that the cell wall material is made up primarily of 
homogalacturonan and rhamnogalacturonan I with long galactan side chains (Thomassen et al., 
2011). Limited research has investigated the use of PF as a dietary fiber source in dogs and humans. 
In vitro data utilizing human fecal inoculum indicates that solubilized PF fractions were 
fermentable and increased bifidobacteria and lactobacillinumbers more than fructo-
oligosaccharides (Thomassen et al., 2011; Olesen et al., 1998; Laerke et al. 2007)  
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 The current research is being reported in two parts: (1) effects of PF on in vitro 
fermentation, and in vivo effects on nutrient digestibility, fecal fermentation end-products, and 
consistency, and (2) assessing the modulatory effects of dietary PF on the fecal microbiome. Our 
laboratory previously published data from part 1, which concluded that PF was a moderately 
fermentable fiber both in vitro and in vivo, and had no detrimental effects on total nutrient 
digestibility or fecal consistency (Panasevich et al., 2013). Part 2 is presented here to investigate 
the effects of graded dietary PF concentrations on modulation of the dog fecal microbiome using 
16S rRNA gene pyrosequencing. We predicted that our previous results (i.e. increases in fecal 
acetate, propionate, and butyrate and a decrease in fecal pH) would be associated with shifts in the 
fecal microbiome (Panasevich et al., 2013).  Based on previous studies involving dietary fiber in 
pets and humans, we predicted that at the phylum level, an increase in fecal Firmicutes and a 
decrease in fecal Fusobacteria would occur (Hooda et al., 2012; Middelbos et al., 2010). More 
specifically, we also predicted increases in Bifidobacterium and other SCFA producing genera 
(e.g. Blautia, Lachnospira, and Faecalibacterium) with increasing dietary PF concentrations.  
Materials and methods 
Animals and diets 
The animal protocol was approved by the University of Illinois Animal Care and Use 
Committee and the study was conducted at the Edward R. Madigan Laboratory at the University 
of Illinois. Ten female dogs with hound bloodlines (6.13 ± 0.17 yr; 22.0 ± 2.1 kg) were utilized in 
a replicated 5 x 5 Latin square design to test five diets in five time periods. Dogs were housed 
individually (2.4 x 1.2 m kennels) in two temperature- and light-controlled rooms. Fresh water was 
available ad libitum.  
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 Five diets containing graded concentrations of PF (0, 1.5, 3, 4.5, or 6% as-is; Roquette 
Frères, Lestrem, France) were formulated to exceed nutrient recommended allowance values of 
adult dogs (Table 2.1), with target concentrations of approximately 26% crude protein and 15% 
crude fat (as-is basis) (NRC, 2006). To achieve similar dietary fiber and protein concentrations 
among diets, PF was added at the expense of cellulose (Solka Floc, International Fiber Corp., 
North Tonawanda, NY) and brewer’s rice. The remainder of the dry, extruded, kibble diet was 
composed of: low-ash poultry by-product meal, poultry fat, brewer’s rice, ground corn, and 
vitamin and mineral premixes. Diets were mixed and extruded at the Kansas State University 
Bioprocessing and Industrial Value-Added Program facility (Manhattan, KS) under the 
supervision of Pet Food and Ingredient Technology, Inc. (Topeka, KS).  
Each of the five, 14-d periods consisted of a 10-d dietary adaptation phase followed by 4-
d of fecal collection. Dogs were offered 155 g diet twice daily (0800 and 1700 h) to meet the 
recommended energy needs of the dog based on the estimated metabolizable energy content of the 
diet. Fresh fecal samples were collected at the same time as was reported previously (Panasevich 
et al., 2013). On d 11, a fresh sub-sample of fecal was collected for analysis of microbial 
populations.  Sub-samples were collected in 2-mL cryovials within 15 min of defecation, snap 
frozen in liquid nitrogen, and stored at -80ᶱ C until DNA extraction. Fecal butyrate determination 
was conducted according to previous methods (Panasevich et al., 2013). Briefly, one aliquot of ~2 
g was collected and placed in ~2 mL of 2N hydrochloric acid and analyzed by gas chromatography 
(Hewlett-Packard 5890A Series II, Palo Alto, CA). and a glass column (180 cm × 4 mm i.d.), 
packed with 10% SP-1200/1% H3PO4 on 80/100 + mesh Chromosorb WAW (Supelco Inc., 
Bellefonte, PA). Nitrogen was the carrier gas with a flow rate of 75 mL/min. Oven, detector, and 
injector temperatures were 125, 175, and 180°C, respectively. 
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 Fecal DNA extraction and 454 pyrosequencing 
 Bacterial DNA was extracted (McInnes and Cutting, 2010) using the MO BIO 
PowerSoilTM Kit (MO BIO Laboratories, Carlsbad, CA). Concentration of extracted DNA was 
quantified using a NanoDrop ND–1000 spectrophotometer (Nano-Drop Technologies, 
Wilmington, DE) and diluted to 10 ng/mL.    
Quality of DNA was assessed by electrophoresis using precast agarose gels (E-Gel® EX 
Gel 1%, Invitrogen, Grand Island, NY). Amplification of a 600-bp sequence of the V4–V6 variable 
region of the 16S rRNA gene was done using barcoded primers (Cephas et al., 2011). Amplicons 
from PCR then were purified further utilizing AMPure XP beads (Beckman-Coulter Inc., 
Indianapolis, IN). Amplicons were combined in equimolar ratios to create a DNA pool that was 
used for pyrosequencing. Quality of DNA from amplicon pools was assessed before 
pyrosequencing using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). 
Pyrosequencing was performed at the W. M. Keck Center for Biotechnology at the University of 
Illinois utilizing a 454 Genome Sequencer and FLX titanium reagents (Roche Applied Science, 
Indianapolis, IN).  
Bioinformatics 
High quality (quality value > 25) sequence data derived from the sequencing process was 
processed using a proprietary analysis pipeline (www.mrdnalab.com) and as described previously 
(Dowd et al., 2008a; Dowd et al., 2008b; Edgar 2010; Capone et al., 2011; Dowd et al., 2011; Eren 
et al., 2011; Swanson et al., 2011). Briefly, sequences were depleted of barcodes and primers, short 
sequences (< 200 bp), sequences with ambiguous base calls, and sequences with homopolymer 
runs exceeding 6 bp. Sequences then were denoised and chimeras were removed. Operational 
taxonomic units (OTU) were defined after removal of singleton sequences and clustering at 3% 
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 divergence (97% similarity). Then, OTUs were taxonomically classified using BLASTn against a 
curated GreenGenes database and compiled into each taxonomic level into both “counts” and 
“percentage” files (Desantis et al., 2006).  
Quantitative PCR (qPCR) 
Quantitative PCR was performed at Texas A&M University according to previous methods 
(Rossi et al., 2014; Malinen et al., 2005). Briefly, primers were targeting group for universal 
bacteria, genus for Lactobacillus, Bifidobacterium, Blautia, Faecalibacterium and Fusobacterium, 
and species for Eschericia coli and Clostridium perfringens. Real-time PCR conditions and 
primers used for Lactobacillus spp., Fusobacteria spp., Blautia spp., Faecalibacterium spp., 
Bifidobacterium spp., and Clostridium perfringens have been described previously (Rossi et al., 
2014). Primers for Eschericia coli were Forward: 5'-GTTAATACCTTTGCTCATTGA-3' and R: 
5'-ACCAGGGTATCTAATCCTGTT-3' (Malinen et al., 2005) with a Tm: 55°C. Standard curves 
were generated using DNA (ranging from 2 ng to 0.2 pg) from lyophilized bacterial species of the 
genera (Faecalibacterium prausnitzii (ATCC 27766); Lactobacillus rhamnosus GG (ATCC 
53103); Bifidobacterium bifidum (ATCC 11863);  Blautia coccoides (ATCC 29236); 
Fusobacterium nucleatum (ATCC 25586)), clinical isolates from E. coli and  C. perfringens, and 
canine fecal community DNA for universal bacteria. The qPCR data was expressed as log amount 
of DNA (fg) for each particular bacterial group per 10 ng of isolated total DNA (Suchodolski et 
al., 2012). 
Statisitcal analyses 
Sequence percentages at each taxonomic level were analyzed using the Mixed models 
procedure of SAS (version 9·2; SAS Institute, Inc. Cary, NC). The fixed effect of treatment was 
tested, and dog and period were considered random effects. ProcUnivariate was used to test for 
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 homogeneity of variance. For data with non-homogeneous variance, observed values were 
reported, and these data were transformed using the log function prior to statistical analysis. Means 
were separated for treatments using a Fisher-protected least significant difference with Tukey’s 
adjustment. Chao 1 values were calculated and rarefaction curves were created to compare 
microbial diversity and species richness among samples. Principal components analysis was 
calculated to determine clustering effects among diets. Results are reported as least-squares means 
with P ≤ 0.05 defined as significant. Means that were above or below 3 standard deviations were 
considered outliers and removed. Post-hoc Pearson’s correlations on the qPCR, sequence, and 
SCFA data were analyzed by the ProcCorr procedure in SAS. Additionally, orthogonal contrasts 
were used to test linear and quadratic effects of providing graded concentrations of dietary PF, and 
all PF treatments (1.5 to 6%) were compared to the 0% PF control using a single degree of freedom 
contrast.  
Results 
Pyrosequencing of 16S rRNA gene barcoded amplicons resulted in a total of 1,040,107 
sequences, with an average of 20,802 reads (range: 10,647 to 56,247) per sample. Samples had an 
average read length of 542 base pairs.  According to Chao 1 values and rarefaction curves (data 
not shown), microbial diversity and species richness was similar among treatments. Principal 
component analysis revealed no clustering amongst dietary treatments (data not shown). 
Regardless of dietary treatment, Firmicutes (22.63 to 94.21% of all sequences) was the 
predominant bacterial phylum in dog fecal, followed by Fusobacteria (0.53% to 58.18% of all 
sequences) and Tenericutes (1.78 to 40.96% of all sequences; Table 2.2). Actinobacteria (0 to 
3.47% of all sequences), Bacteroidetes (0 to 9.06% of all sequences), and Proteobacteria (0 to 
12.53% of all sequences) also were present. Inclusion of graded PF concentrations in canine diets 
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 altered the proportions of bacterial phyla in the canine fecal microbiome. With increasing PF 
concentrations, the proportion of Firmicutes exhibited a positive quadratic response (P < 0.05), 
with the highest concentration observed in dogs fed the 4·5% PF diet. Fusobacteria exhibited a 
negative quadratic response (P < 0.05), with the lowest proportion observed in dogs fed the 4·5% 
PF diet. Tenericutes decreased linearly (P < 0.05) with increasing dietary PF concentrations.   
Fusobacterium (0.53% to 58.18% of all sequences), Clostridium (3.21 to 61.35% of all 
sequences), Blautia (1.77 to 26.38% of all sequences), and Faecalibacterium (0.20 to 27.99% of 
all sequences) were the predominant genera in dog fecal (Table 2.2). The proportion of 
Fusobacterium exhibited a negative quadratic response (P < 0.05), with the lowest concentrations 
observed when dogs were fed the 4.5% PF diet. Within the phylum of Firmicutes, Clostridium was 
the predominant genera for dogs fed 0 to 4.5% PF. For dogs fed 6% PF, the proportion of 
Clostridium was lower (P < 0.05) than that for dogs fed the 0, 3, or 4.5% PF diets, while 
Faecalibacterium was greater (P < 0.05) than that for dogs fed the 0, 1.5, or 3% PF diets. The 
proportion of Clostridium exhibited a quadratic response (P < 0.05) with increasing dietary PF 
concentrations, with dogs fed 6% PF having lower proportions (P < 0.05) compared to dogs fed 
0% PF. The proportions of Faecalibacterium and Lachnospira were greater (P < 0.05) for dogs 
fed all diets containing PF compared to those fed 0% PF. Faecalibacterium increased linearly (P 
< 0.05), while Lachnospira increased quadratically (P < 0.05),  with increasing dietary PF. The 
proportions of Blautia increased quadratically (P < 0.05), with peak proportions observed when 
dogs were fed the 4.5% PF diet. For fecal Coprobacillus, there was also a quadratic increase (P < 
0.05), with peak proportions observed when dogs were fed the 1.5 and 3% PF diets. The 
proportions of Prevotella (member of Bacteroidetes) and Succinivibrio (member of 
Proteobacteria) were lower (P < 0.05) for dogs fed all PF-containing diets compared with dogs fed 
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 the 0% PF diet, and also exhibited a linear decrease (P < 0.05) with increasing dietary PF 
concentration. Bacterial species also were quantified and are presented as a supplementary table 
(Table 2.3). 
Quantitative PCR was conducted on select groups of bacteria (universal bacteria), genera 
and species. Figure 2.1 shows the scatter plots of sequence and qPCR data with median values, 
and Pearson’s correlation scatter plots of qPCR vs. 454-pyrosequencing for Faecalibacterium spp., 
Fusobacterium spp., and Blautia spp. Fecal Faecalibacterium, Fusobacterium, and Blautia spp. 
showed no significant diet effects with increasing concentrations of PF in the diet (P = 0.10, 0.07, 
and 0.32, respectively; means are not shown). A single degree of freedom contrast of the qPCR 
data calculating the difference between 0% PF vs all other diets containing PF revealed that fecal 
Faecalibacterium spp. were higher (P < 0.05) in dogs fed PF-containing diets compared to the 0% 
PF diet. Fecal Fusobacterium spp. were lower (P < 0.05) for dogs fed PF-containing diets 
compared to the 0% PF diet. There was a positive correlation between the sequence and qPCR 
data for Faecalibacterium spp. (R = 0.64; P < 0.01) and Blautia spp. (R = 0.69; P < 0.01). There 
was no correlation between sequence and qPCR data for Fusobacterium spp. (R = 0.10; P < 0.44).  
Scatter plots for qPCR of Bifidobacterium and Lactobacillus spp. with median values and 
Pearson’s correlation plots of Bifidobacterium spp. and butyrate and Lactobacillus spp. and 
Bifidobacterium spp. are shown in Figure 2.2. There were no differences in mean values (data not 
shown) for Bifidobacterium spp. and Lactobacillus spp. among dietary treatments; however, there 
were significant correlations between Bifidobacterium spp. and butyrate (R = 0.49; P < 0.01) and 
Lactobacillus and Bifidobacterium spp. (R = 0.82; P < 0.01). Scatter plots for Escherichia coli and 
Clostridium perfringens 16S are presented as a supplementary figure (data not shown).   
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 Discussion 
 Part 1 of this study investigated the viability of PF as a potential dietary fiber source in dog 
foods by evaluating: (1) the fermentability of PF in vitro and (2) nutrient digestibility, fecal 
consistency, and fermentability of graded concentrations of dietary PF in vivo (Panasevich et al., 
2013). Results from part 1 indicated that PF was fermentable through 9 h of in vitro fermentation, 
and showed linear increases in fecal acetate, propionate, and butyrate with increasing dietary PF 
concentrations (Panasevich et al., 2013). It was concluded that PF was moderately fermentable 
and showed no detrimental effects on total tract nutrient digestibilities or fecal consistency 
(Panasevich et al., 2013). The increased concentration of fecal SCFA, and in particular, butyrate, 
as well as decreases in fecal pH, were noted as being a benefit to host health. It is well known that 
SCFA have numerous benefits to the host, including improved gut health, satiety promotion, and 
attenuated inflammation (Wong et al., 2005; Tohurst et al., 2012; Vinolo et al., 2011). 
Furthermore, a decrease in fecal pH with increasing concentrations of dietary PF suggests 
carbohydrate fermentation throughout the entire length of the colon. After observing these 
beneficial changes in part 1, our objective in part 2 was to identify microbial taxa altered by the 
graded concentrations of dietary PF.  
 There is limited research investigating the use of PF as a dietary fiber source. The fiber 
fraction of potato fiber consists of 55% total dietary fiber, with 32% insoluble fiber and 23% 
soluble fiber. Specifically, the insoluble fiber fraction is predominantly cellulose (16%) and 
hemicellulose (9%). Pectin is the main component of the soluble fiber fraction of potato fiber. A 
study in rats reported that the soluble fiber fraction of PF resulted in higher cecal short-chain fatty 
acid concentrations compared to rats fed a non-fermentable cellulose control (Laerke et al., 2007). 
Research in humans indicated that the consumption of enzymatically-solubilized PF elicited 
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 increased fermentation by increasing breath H2 compared to oat bran (Olesen et al., 1998). 
Furthermore, in vitro data using human fecal inoculum indicated that solubilized PF that was 
minimally treated enzymatically was more bifidogenic than fructo-oligosaccharide (Thomassen et 
al., 2011). The chemical composition, in vitro fermentation, and in vivo responses, suggest PF has 
prebiotic potential; however, the effects of graded concentrations of dietary PF on the hindgut 
microbiome have yet to be studied. 
Previous studies have investigated the modulatory effects of fiber on the hindgut 
microbiome in both dogs and humans (Hooda et al., 2012; Middelbos et al., 2010). We concluded 
from our previous work that PF is moderately fermentable in vitro and in vivo (Panasevich et al., 
2013). Therefore, our diet formulation sought to keep total dietary fiber concentrations constant 
amongst all diets, while only changing the amount of PF at the expense of an inert fiber, cellulose. 
With this unique diet formulation, this study is the first to utilize high-throughput 16S rRNA gene-
based pyrosequencing to determine how increasing concentrations of a moderately fermentable 
fiber modulates the hindgut microbiota of dogs.  
Previous data indicated that a healthy dog fecal microbiome consists of approximately 14 
to 52.5% Firmicutes and 7 to 50% Fusobacteria (Middelbos et al., 2010; Swanson et al., 2011; 
Handl et al., 2013; Suchodolski et al., 2008). The predominant bacterial phyla present in fecal of 
dogs fed all diets were Firmicutes and Fusobacteria. The order of predominant fecal bacterial phyla 
found in this study was different compared to other studies investigating the dog fecal microbiome. 
These differences could be explained by the variable regions of the 16S rRNA being amplified. 
For example, Middelbos et al. (2010) found healthy dogs to have predominantly Fusobacteria, 
followed by Firmicutes and Bacteroides, when amplifying the V3 region of 16S rRNA. Similarly, 
studies investigating the V1-V3 regions of 16S rRNA found very high proportions of Firmicutes 
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 (96% OTUs) and very low proportions of other bacterial phyla.  Our study investigated the V4-V6 
regions of 16S bacterial rRNA, which resulted in different proportions of predominant bacterial 
phyla; however, the shifts in the microbiome are consistent with fiber supplementation (Middelbos 
et al., 2010). The supplementation of beet pulp has been found to increase the ratio of 
Firmicutes:Fusobacteria (Middelbos et al., 2010). A similar pattern was found in this study where 
increasing dietary PF concentrations elicited a quadratic increase in fecal Firmicutes and a 
quadratic decrease in fecal Fusobacteria.  
Fermentability of fibrous substrates is dependent on the chemical composition, physical 
form, and amount of substrate available (Macfarlane and Macfarlane, 2003). The heat, pressure, 
and moisture applied in extrusion usually increases the availability of substrate for microbes to 
ferment and produce SCFA. Typically, the molar concentrations of SCFA in the hindgut are 
greatest in acetate, then propionate, and butyrate often is present in the lowest concentration. 
Butyrate is a major energy source for colonocytes and promotes cell apoptosis, stimulation of cell 
proliferation, and prevention of colon cancer (Hamer et al., 2008). Part 1 of this study found 
increases in all three SCFA with increasing dietary PF. Changes within the Firmicutes phylum 
with increasing PF was consistent with our results on fecal SCFA, and provides some insight about 
the physiologic relevance of this study.   
Diversity within the phylum Firmicutes is indicative of a reduced risk of certain hindgut 
diseases, as well as concentrations of a diet containing fermentable carbohydrates (Hooda et al., 
2012; Middelbos et al., 2010; Manichanh et al., 2006). Increases in butyrate and other SCFA also 
may be revealing of shifts in the hindgut microbiome (Wong et al., 2006). Our results do not show 
increased diversity within the phylum Firmicutes; however, we show an increase in abundance of 
key fermenters. We show an increase in Faecalibacterium spp. with increasing dietary PF, which 
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 was consistent with previous studies examining fermentable fiber in dog and human diets (Hooda 
et al., 2012; Middelbos et al., 2010). Dogs ingesting beet pulp, a moderately fermentable fiber with 
a similar chemical composition to PF, were found to have more Faecalibacterium prausnitzii 
represented in fecal samples compared to dogs provided no fiber (Middelbos et al., 2010). This 
bacterium has received increased attention due to the human literature suggesting its protective 
effects in IBD (Sokol et al., 2008; Ramirez-Farias et al., 2009). In dogs, it generally has been 
accepted as a beneficial bacterium due to its depletion in IBD and its ability to produce butyrate; 
however, its physiologic relevance has not been fully elucidated (Suchodolski et al., 2012; Louis 
et al., 2010). Our qPCR analysis of this bacterium confirm its presence, and the analysis was highly 
correlated with our sequencing data. Furthermore, both the sequencing and qPCR data show 
similar patterns of increased concentrations of Faecalibacterium with increasing dietary PF.  
Fecal Blautia and Fusobacterium spp. were two genera that were abundant in our 
sequencing data and were confirmed by qPCR. There was a significant positive correlation 
between qPCR and sequencing data when analyzing fecal Blautia spp., but no significant 
correlation was observed with Fusobacterium spp. This result was not entirely surprising, since 
our previous publications using these primers tended to have a bias towards Fusobacterium spp. 
(Middelbos et al., 2010; Swanson et al., 2011).  The qPCR data did not show significant diet 
effects; however, the pattern noticed with increasing PF seemed to be similar with the sequence 
data. In dogs, low fecal concentrations of Blautia spp. have been associated with acute-
hemorrhagic diarrhea and are a part of the butyrate producing superfamily, Lachnospiraceae. 
Fusobacterium spp. have previously been reported to have associations with liver cirrhosis and 
oral cavity infections in humans (Swidsinski et al., 2011; Bennett and Eley, 1993); however, the 
presence of this bacterial phyla is common in healthy dogs (Middelbos et al., 2010; Tolhurst et al., 
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 2012; Vinolo et al., 2011). An increase in fecal Blautia spp. and a decrease in fecal Fusobacterium 
spp. are consistent with dietary fiber intake data (Middelbos et al., 2010).   
 The physiologic relevance of these results was further investigated by conducting post-hoc 
Pearson’s correlation analysis with fecal SCFA data reported previously and qPCR data 
(Panasevich et al., 2013). Prebiotics often are evaluated by their ability to produce butyrate (a 
butyrogenic effect) or to stimulate the growth of bifidobacteria (a bifidogenic effect); however, the 
definition of a prebiotic is not limited to this genus (De Vuyst and Leroy, 2011; Tremaroli and 
Backhed, 2012). We found Bifidobacterium spp. were positively correlated with butyrate and 
lactobacilli concentrations. Bifidobacteria’s main carbohydrate fermentation products are acetate 
and lactate when substrate is available (Suchodolski et al., 2008), while lactobacilli produce lactic 
acid. Bifidobacteria growth has been found to accompany butyrate concentrations with inulin-type 
fructans (De Vuyst and Leroy, 2011). This has previously been explained by bacterial cross-
feeding where primary fermenters of carbohydrate will produce secondary metabolites (acetate 
and lactate) or hydrolyzed substrate that can be utilized by other bacteria (De Vuyst and Leroy, 
2011). Pectic oligosaccharides have been found to increase bifidobacteria in vitro; however, the 
effect is dependent on degree of methylation, and it was concluded oligo-fructose was more 
bifidogenic (Olano-Martin et al., 2002). An in vitro fermentation study utilizing human fecal 
inoculum found that solubilized PF that had minimal enzymatic treatment was more bifidogenic 
than fructooligosaccharide (Thomassen et al., 2011). The positive correlations between 
Bifidobacterium spp. with butyrate concentrations and lactobacilli growth further suggest the 
prebiotic potential of PF; however, the bifidogenic properties of PF need to be investigated further.  
 In conclusion, increasing concentrations of dietary PF were found to modulate the fecal 
microbiome at the phylum and genus taxonomic levels. This was confirmed by qPCR where fecal 
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 Faecalibacterium and Blautia spp. showed significant positive correlations with the 454-
pyrosequencing data. Furthermore, part 1 of this study found increases in fecal acetate, propionate, 
and butyrate with increasing dietary PF, which appears to agree with changes in the fecal 
microbiome. Post-hoc correlative analysis also showed significant correlations with 
Bifidobacterium spp. with butyrate concentrations and Lactobacillus spp. concentrations. One 
potential pitfall to this study that should be noted is the use of BLAST to infer taxonomy instead 
of an RDP classifier. Inferences made in this study were only on bacterial group’s sequences 
confirmed by qPCR and at the phylum and genus taxonomic levels. It has been previously noted 
that only small differences exist between RDP and BLAST at higher taxonomic levels (Jumpstart 
Consortium, 2012).Overall, this research suggests that PF is beneficial to gut health and should be 
investigated as a novel functional ingredient in dog diets.  Future research investigating other novel 
fiber sources effects on the microbiome could help explain how different clusters of bacterial 
families and genera respond to fermentable substrates. 
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Table 2.1.  Ingredient and chemical composition of experimental diets fed to dogs 
                                                         % potato fiber (PF)*  
Items  0 1.5 3 4.5 6 
Ingredient (% as fed)      
  Brewer's rice                              46.55   45.90   45.25   44.60      43.95 
  Poultry byproduct meal-low ash            25.50   25.50   25.50   25.50   25.50 
  Corn, yellow, ground                      12.00   12.00   12.00   12.00   12.00 
  Poultry fat                                 8.00     8.00     8.00     8.00     8.00 
  Potato fiber†                             0.00     1.50     3.00     4.50     6.00 
  Cellulose§     6.00     5.15     4.30     3.45     2.60 
  Salt                                        0.70     0.70     0.70     0.70     0.70 
  Potassium chloride                          0.56     0.56     0.56     0.56     0.56 
  Chromic oxide                               0.20     0.20     0.20     0.20     0.20 
  Mineral mix|     0.18     0.18     0.18     0.18     0.18 
  Vitamin mix¶     0.18     0.18     0.18     0.18     0.18 
  Choline chloride-50%                        0.13     0.13     0.13     0.13     0.13 
Chemical composition (% DM)      
  Dry matter  95.75   95.65 95.51    95.45   95.29 
                                ---------------------- % dry matter basis ---------------------- 
  Organic matter   94.21   94.36 94.24    94.07   94.20 
  Crude protein   25.10   24.78 24.91    25.20   25.14 
  Acid-hydrolyzed fat   13.45   14.51 14.48    14.17   13.05 
  Total dietary fiber   10.79   11.24 11.43    11.17   11.35 
  Gross energy (kJ/g)   20.79   20.96     20.92    20.96   20.67 
*Diet formulations contained raw PF at the specified concentrations; diets were extruded to 
produce the food provided to the dogs. 
†Roquette Frères, Lestrem, France. 
§Solka-Floc, International Fiber Corp., North Tonawanda, NY. 
|Provided per kilogram of diet: Mn (as MnSO4), 66.00 mg; Fe (as FeSO4), 120 mg; Cu (as 
CuSO4), 18.00 mg; Co (as CoSO4), 1.20 mg; Zn (as ZnSO4), 240 mg; I (as KI), 1.80 mg; Se 
(as Na2SeO3), 0.24 mg. 
¶Provided per kilogram of diet: vitamin A, 5.28 mg; vitamin D3, 0.04 mg; vitamin E, 120.00 
mg; vitamin K, 0.88 mg; thiamine, 4.40 mg; riboflavin, 5.72 mg; pantothenic acid, 22.00 mg; 
niacin, 39.60 mg; pyridoxine, 3.52 mg; biotin, 0.13 mg; folic acid, 0.44 mg; vitamin B12, 0.11 
mg. 
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Table 2.2. Predominant bacterial phyla and genera (expressed as a percentage of total sequences) in feces of dogs fed diets containing graded 
potato fiber (PF) concentrations§ 
   % PF   
Phylum Family Genus   0       1.5 3       4.5      6 SEM P- 
Value 
Actinobacteria       0.23ab     0.27ab     0.20ab     0.54b   0.10a 0.22 0.03 
 Bifidobacteriaceae Bifidobacterium     0.44     0.25     0.17     0.52   0.09 0.23 0.17 
Bacteroidetes       1.17     0.70     1.17     1.05   0.73 0.33 0.57 
 Bacteroidaceae Bacteroides     0.39     0.43     0.70     0.47   0.51 0.20 0.72 
 Prevotellaceae Prevotella‡     0.78b     0.27a     0.47ab     0.59ab   0.26a 0.42 0.02 
Firmicutes     56.66   64.33   64.52   68.20 58.17 5.99 0.17 
 Clostridiaceae Clostridium†   26.54b   23.00ab   26.96b   26.63b 14.61a 5.62 0.01 
 Eubacteriaceae Eubacterium     0.79     1.27     0.95     1.10   0.57 0.32 0.46 
 Lachnospiraceae Blautia†   11.27   12.24   12.50   13.29 10.40 2.11 0.22 
  Lachnospira‡†     0.02a     0.92ab     1.52b     1.57b   1.51b 0.42 0.01 
  Roseburia     0.83     0.70     0.29     0.76   0.33 0.27 0.37 
 Lactobacillaceae Lactobacillus     1.27     5.26     1.99     2.94   4.46 2.43 0.71 
 Peptococcaceae Delsulfotomaculum     1.26     1.26     0.84     0.70   0.88 0.40 0.48 
 Ruminococcaceae Faecalibacterium‡*     4.64a     9.38a     9.57a   10.23ab 15.69b 2.07 0.01 
  Oscillospira     0.72     0.76     0.71     0.72   0.46 0.19 0.60 
  Ruminococcus     5.49     5.26     4.63     4.93   4.72 1.05 0.86 
 Turcibacteraceae Turicibacter     0.89     0.67     0.96     1.02   0.66 0.27 0.49 
 Veillonellaceae Megamonas     0·62     0·71     0·80     1·03   0·96 0·38 0·93 
  Phascolarctobacterium     3.30     3.57     3.65     3.45   3.49 0.85 0.99 
Fusobacteria†     27.44   25.84   23.01   20.29 32.28 4.80 0.17 
 Fusobacteriaceae Fusobacterium†   27.44   25.84   23.01   20.29 32.28 4.80 0.17 
Proteobacteria       1.53     1.77     1.80     2.72   2.78 0.83 0.62 
 Succinivibrionaceae Succinivibrio‡*     0.08     0.23     0.19     0.31   0.29 0.11 0.18 
 Alicaligenaceae Sutterella     1.39     1.53     1.52     2.00   2.43 0.77 0.82 
Tenericutes*     12.74     7.09     9.29     7.20   5.20 2.52 0.18 
 Erysipelotrichaceae Allobaculum   10.52     4.31     6.38     5.28   3.57 2.55 0.67 
  Bulleidia     0.21     0.18     0.22     0.15   0.16 0.06 0.57 
  Catenibacterium     0.14     0.12     0.07     0.07   0.04 0.06 0.68 
  Coprobacillus†     0.38     0.51     0.51     0.45   0.25 0.13 0.26 
  Holdemania     0.07     0.10     0.08     0.08   0.04 0.04 0.59 
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Table 2.2 continued. Predominant bacterial phyla and genera (expressed as a percentage of total sequences) in feces of dogs fed diets 
containing graded potato fiber (PF) concentrations§ 
§Genera included have LSMEANs of 0.01 or higher. 
abMeans in the same row with unlike superscript letters differ (P < 0.05). 
‡ Difference between 0% PF vs. all other PF diets (P < 0.05). 
*Linear effect (P < 0.05). 
†Quadratic effect (P < 0.05). 
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 Table 2.3. Predominant bacterial species (expressed as a percentage of total sequences) in feces of dogs fed diets 
containing graded potato fiber (PF) concentrations§ 
 % PF   
Species 0  1.5 3  4.5     6 SEM P-Value 
Bifidobacterium pseudolongum   0.21ab    0.24ab   0.15ab    0.50b   0.09a 0.17 0.04 
Prevotella copri‡   0.68b    0.24a   0.40ab    0.52ab   0.22a 0.36 0.02 
Clostridium bifermentans   0.40    0.37   0.56    0.75   0.40 0.27 0.59 
C. citroniae‡*   0.06    0.09   0.15    0.17   0.15 0.03 0.05 
C. disporicum   0.01    0.02   0.02    0.03   0.03 0.01 0.89 
C. hiranonis* 19.57b  16.64ab 19.64b  19.29b 10.42a 4.37 0.02 
C. incertae sedis†   0.18    0.37   0.33    0.48   0.14 0.17 0.18 
C. lactatifermen†   0.01    0.06   0.06    0.11   0.02 0.03 0.12 
C. metallolevans   0.03    0.05   0.08    0.07   0.04 0.03 0.39 
C. spiroforme   0.42    0.36   0.52    0.22   0.21 0.14 0.25 
Allobaculum stercoricanis#†   2.51    3.42   3.83    2.72   2.45 0.84 0.16 
Catenibacterium mitsuokai   0.13    0.11   0.06    0.06   0.03 0.05 0.64 
Coprobacillus cateniformis   0.12    0.15   0.16    0.15   0.11 0.04 0.86 
Turicibacter sanguinis   0.70    0.55   0.77    0.80   0.55 0.23 0.62 
Eubacterium biforme   0.20    0.35   0.29    0.46   0.34 0.15 0.62 
E. dolichum   0.15    0.18   0.10    0.09   0.04 0.06 0.24 
Blautia producta†   6.33    7.81   7.61    7.56   5.98 1.34 0.31 
Ruminococcus obeum   1.29ab    0.81a   1.44ab    2.32b   0.97ab 0.51 0.03 
R. gnavus   1.04    0.94   0.83    1.06   0.60 0.38 0.38 
R. torques   0.33    0.32   0.52    0.35   0.49 0.18 0.84 
Lactobacillus acidophilus   0.11    0.05   0.09    0.07   0.09 0.07 0.96 
L. johnsonii   0.68    3.54   0.66    2.04   3.45 1.82 0.62 
L. reuteri (strain F275)   0.19    0.68   0.17    0.54   0.53 0.34 0.72 
Faecalibacterium prausnitzii‡*   4.15a    8.67a   8.89a    9.63a 14.88b 2.00 0.01 
Lactococcus lactis lactis   0.14    0.46   0.05    0.12   0.01 0.16 0.36 
Fusobacterium varium 15.51  16.77 14.21  12.34 18.35 2.76 0.22 
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Table 2.3 continued. Predominant bacterial species (expressed as a percentage of total sequences) in feces of 
dogs fed diets containing graded potato fiber (PF) concentrations§ 
§Genera included have LSMEANs of 0.01 or higher. 
abMeans in the same row with unlike superscript letters differ (P < 0.05). 
‡ Difference between 0% PF vs. all other PF diets (P < 0.05). 
*Linear effect (P < 0.05). 
†Quadratic effect (P < 0.05). 
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Figure 2.1. Row A: Faecalibacterium spp. scatter plots for the sequencing data, qPCR data, and 
Pearson’s correlation  analysis for sequence vs. qPCR data. Row B: Fusobacterium spp. scatter 
plots for sequencing data, qPCR data, and Pearson’s correlation  analysis for sequence vs. qPCR 
data. Row C: Blautia spp. scatter plots for the sequencing data, qPCR data, and Pearson’s 
correlation analysis for sequence vs. qPCR data.*LSMEANs show a linear effect (P < 
0.05); #LSMEANs show a quadratic effect (P < 0.05); XLSMEANs show a difference between 
0% PF vs. all other PF diets (P < 0.05). Legend for Pearson’s correlation plots: closed dots = 0% 
PF diet; closed triangle = 1.5% PF diet; open dot = 3% PF diet; open triangle = 4.5% PF diet; 
square = 6% PF diet. 
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 Bifidobacterium  qPCR scatter plot
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Figure 2.2. Row A: Scatter plots of qPCR data for Bifidobacterium and Lactobacillus spp. Data 
are represented as replicate values with a line to denote the median of each treatment group. Row 
B: Pearson’s correlation plots for Bifidobacterium spp. qPCR data and butyrate and 
Lactobacillus spp. qPCR data and Bifidobacterium spp. Legend for row B: closed dots = 0% PF 
diet; closed triangle = 1.5% PF diet; open dot = 3% PF diet; open triangle = 4.5% PF diet; square 
= 6% PF diet. 
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 CHAPTER 3: EVALUATION OF SOLUBLE CORN FIBER ON CHEMICAL 
COMPOSITION AND TMEn AND ITS EFFECTS ON IN VITRO FERMENTATION 
AND IN VIVO RESPONSES IN DOGS1 
Abstract  
Dietary fermentable fiber is known to benefit intestinal health of companion animals. 
Soluble corn fiber (SCF) was evaluated for its chemical composition, nitrogen-corrected true 
metabolizable energy (TMEn) content, in vitro digestion and fermentation characteristics, and in 
vivo effects on nutrient digestibility, fecal fermentation end-products, and modulation of the fecal 
microbiome of dogs. Soluble corn fiber contained 78% total dietary fiber, all present as soluble 
dietary fiber; 56% was low-molecular weight soluble fiber (did not precipitate in 95% EtOH). The 
SCF also contained 26% starch and 8% resistant starch, and had a TMEn value of 2.6 kcal/g. 
Soluble corn fiber was first subjected to in vitro hydrolytic-enzymatic digestion to determine extent 
of digestibility, then fermented using dog fecal inoculum, with fermentative outcomes measured 
at 0, 3, 6, 9, and 12 h. Hydrolytic-enzymatic digestion of SCF was only 7%. In vitro fermentation 
showed increased (P < 0.05) concentrations of short-chain fatty acids (SCFA) through 12 h, with 
acetate, propionate, and butyrate reaching peak concentrations of 1,803, 926, and 112 µmol/g DM, 
respectively. Fermentability of SCF was higher (P < 0.05) than for cellulose but lower (P < 0.05) 
than for pectin. In the in vivo experiment, ten female dogs (6.4 ± 0.2 yr; 22 ± 2.1 kg) received 5 
diets with graded concentrations of SCF [0, 0.5, 0.75, 1.0, or 1.25% (as-is basis)] replacing 
cellulose in a replicated 5 x 5 Latin square design.  
   
1Panasevich, M. R., K. R. Kerr, M. C. Rossoni Serao, M. R. C. de Godoy, L. Guérin-Deremaux, 
G. L. Lynch, D. Wils, S. E. Dowd, G. C. Fahey, Jr., K. S. Swanson, and R. N. Dilger. 
2015 J. Anim. Sci. (in press). 
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Dogs were first acclimated to the experimental diets for 10 d followed by 4 d of total fecal 
collection. Fresh fecal samples were collected to measure fecal pH and fermentation end-products, 
and permit a microbiome analysis. For microbiome analysis, extraction of DNA was followed by 
amplification of the V4-V6 variable region of the 16S rRNA gene using barcoded primers. 
Sequences were classified into taxonomic levels using BLASTn against a curated GreenGenes 
database (accessed January, 2012).  Few changes in nutrient digestibility or fecal fermentation 
end-products or stool consistency were observed, and no appreciable modulation of the fecal 
microbiome occurred. In conclusion, soluble corn fiber was fermentable in vitro, but higher dietary 
concentrations may be necessary to elicit potential in vivo responses. 
Introduction 
Prebiotic fibers in pet foods are becoming increasingly popular due to their favorable 
effects on gut function and health by increased concentrations of SCFA and changes in the 
intestinal microbiota (Propst et al., 2003).  Most prebiotic fibers are rapidly fermentable, and if 
added at high concentrations to the diet, could result in negative digestive physiologic outcomes 
such as poor stool consistency and nutrient digestibility. Therefore, it is important to determine 
appropriate dietary concentrations of prebiotic fibers that modulate the microbiome and increase 
fermentation characteristics without affecting nutrient digestibility and (or) stool consistency. 
Common prebiotic fibers often added to pet foods include inulin and oligofructose that 
promote SCFA concentrations and modulation of the microbiome (Propst et al., 2003). Low 
digestible carbohydrates are chemically-modified starches that increase SCFA concentrations and 
modify the microbiota in humans and animal models; however, neither the fermentation 
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 characteristics nor the altering effects of the fecal microbiome has been studied to any extent in 
dogs.   
Soluble corn fiber (NUTRIOSE® FM; Roquette; Lestrem, France) is a novel low digestible 
carbohydrate derived from hydrolysis of corn starch by heat and acid. Upon cooling, reformation 
of mixed β-glycosidic linkages resistant to mammalian enzymatic hydrolysis occurs. Soluble corn 
fiber is commonly used in the human food industry to aid in colonic health and as a low glycemic 
food additive (Knapp et al., 2010). Previous research has found it to be fermentable and have 
positive effects on changing the colonic microbiome of humans and rats; however, there is limited 
research on its use in dog foods. Therefore, the objectives of this research were to evaluate SCF 
for nutrient composition, in vitro digestion and fermentability, and in vivo responses (i.e., nutrient 
digestibility, fermentation end-products, and shifts in the intestinal microbiota) in dogs. 
Materials and methods 
Chemical analyses 
 Soluble corn fiber (NUTRIOSE®FM; Roquette Frères, Lestrem, France), experimental 
diets, and fecal samples were analyzed for dry matter (DM), organic matter, and ash according to 
standardized procedures (AOAC, 2006; methods 934.01 and 942.05). Crude protein was calculated 
from Leco (models FP2000 and TruMac; LECO Corp., St. Joseph, MI) total nitrogen values 
(AOAC, 2006; method 992.15). Total starch concentration of SCF was determined according to 
AOAC (2006; method 979.10). Total lipid content (acid-hydrolyzed fat) of each substrate was 
determined according to the methods of the American Association of Cereal Chemists (1983) and 
Budde (1952). Total dietary fiber, high-, and low-molecular weight soluble fiber of SCF were 
determined by AOAC (2005; method 2001.03). Briefly, high-molecular weight soluble fiber was 
determined as the portion that precipitated in 95% EtOH, while low-molecular weight soluble fiber 
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 that did not precipitate in 95% EtOH was determined by HPLC. Experimental diets were analyzed 
for total dietary fiber, insoluble dietary fiber, and soluble dietary fiber concentrations according to 
Prosky et al. (1992). Free glucose and digestible starch concentrations were determined according 
to Muir and O’Dea (1993). Resistant starch was determined by subtracting digestible starch and 
free glucose from total starch concentration. Gross energy was measured using an oxygen bomb 
calorimeter (model 1261, Parr Instruments, Moline, IL). Free monosaccharide and oligosaccharide 
concentrations were determined according to Smiricky et al. (2002).  
Fecal SCFA and branched-chain fatty acid (BCFA) concentrations were determined by gas 
chromatography according to Erwin et al. (1961) using a gas chromatograph (model 5890A series 
II, Hewlett-Packard, Palo Alto, CA) and a glass column (180 cm x 4 mm i.d.) packed with 10% 
SP-1200/1% H3PO4 on 80/100+ mesh Chromosorb WAW (Supelco Inc., Bellefonte, PA). 
Nitrogen was the carrier with a flow rate of 75 mL/min. Oven, detector, and injector temperatures 
were 125, 175, and 180°C, respectively. Fecal ammonia concentrations were determined according 
to the method of Chaney and Marbach (1962). Fecal phenol and indole concentrations were 
determined using gas chromatography according to the methods described by Flickinger et al. 
(2003). Biogenic amine concentrations were quantified using HPLC according to methods 
described by Flickinger et al. (2003).   
In vitro hydrolytic digestion/fermentation simulation 
 The in vitro hydrolytic digestion/fermentation study was conducted according to 
Panasevich et al. (2013) with some modifications. Briefly, approximately 500 mg of SCF was 
weighed in triplicate and incubated with 12.5 mL phosphate buffer and 5 mL of a 
pepsin/hydrochloric acid solution at 39°C to simulate gastric digestion. After 6 h, the pH was 
adjusted to 6.8, and 5 mL pancreatin solution (Sigma-Aldrich Co., St. Louis, MO) was added to 
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 each tube. Incubation continued at 39°C for 18 h to simulate small intestinal digestion (Boisen and 
Eggum, 1991). The set of samples prepared for enzymatic digestion then was assayed for released 
free sugars to correct for free glucose entering the in vitro fermentation.  
 In vitro fermentation was performed using a modification of the method of Bourquin et al. 
(1993). Following the in vitro digestion procedures described above, samples were hydrated 
overnight in 26 mL of anaerobic media. Fecal samples from three dogs were collected within 10 
min of defecation and maintained at 39°C to prepare fresh inoculum. Prior to collection of feces, 
dogs had been maintained on a commercially-available food for 1 mo (Iams weight control, Procter 
& Gamble Pet Care, Cincinnati, OH). The fecal inoculum was prepared by blending 10 g of each 
fecal sample with 90 mL anaerobic diluting solution for 15 sec in a Waring blender under a stream 
of CO2. The resulting solution was filtered through 4 layers of cheesecloth and sealed in 125 mL 
serum bottles pending the in vitro experiment. 
 Samples, blanks, and standards were inoculated with 4 mL of diluted feces. Solka floc 
(International Fiber Corp., North Tonawanda, NY) and high-methoxy pectin (TIC Gums Inc., 
Belcamp, MD) were used as negative and positive fermentation controls, respectively. Tubes were 
incubated at 39°C with periodic mixing. A subset of tubes was removed from the incubator at 0, 
3, 6, 9, and 12 h post-inoculation and processed immediately for analyses. A 2 mL subsample of 
the fluid was removed and acidified for SCFA and BCFA analyses. Concentrations of SCFA and 
BCFA were determined by gas chromatography as described previously.  
In vivo studies 
 Rooster study: True metabolizable energy  
A nitrogen-corrected true metabolizable energy (TMEn) coefficient was determined using 
conventional single comb white leghorn roosters (n = 4) according to Kim el al. (2010). Briefly, 
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 roosters were deprived of feed for 24 h and then crop-intubated with approximately 15 g of SCF 
and 15 g of corn with a known gross energy and nitrogen value (Sibbald et al., 1980). Roosters 
were crop intubated and excreta (urine plus feces) were collected for 48 h on plastic trays placed 
under each cage. Excreta samples were subsequently lyophilized, weighed, and ground to pass a 
60-mesh screen and analyzed for gross energy content as described for samples above.  
Endogenous corrections for energy were made using roosters that had been food-deprived for 48 
h. The TMEn values, corrected for endogenous energy losses, were calculated using the following 
equation: 
TMEn (kcal/g) =   
 
(g) intake Feed
(kcal) birds fastedby  excretedenergy   (kcal) birds fedby  excretedenergy   -(kcal) intakeEnergy +
 
 
Dog study: Animals and diets 
Ten female dogs with hound bloodlines (6.4 ± 0.2 yr; 22 ± 2.1 kg) were utilized. Dogs were 
housed in individual kennels (2.4 x 1.2 m) in two temperature-controlled rooms with a 16 h light:8 
h dark cycle. A replicated 5 x 5 Latin square design experiment was conducted with 5 diets and 10 
dogs in two different rooms for five, 14-d periods. The first 10 d of each period served as an 
adaptation phase, followed by 4 d of total fecal collection. Five diets containing SCF were 
formulated to contain approximately 32% CP and 18% crude fat (DM basis; Table 4.1). Each diet 
contained graded concentrations of SCF [0, 0.5, 0.75, 1.0, or 1.25% (as-is basis)] that replaced 
cellulose (Solka floc; International Fiber Corp., North Tonawanda, NY) in the diet. Low-ash 
poultry by-product meal, poultry fat, brewer’s rice, ground corn, and vitamin and mineral premixes 
constituted the remainder of the dry, extruded, kibble diets. All diets were formulated to exceed 
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 NRC (2006) recommended allowances for an adult large breed dog. Diets were mixed and 
extruded at the Kansas State University Bioprocessing and Industrial Value-Added Program 
facility (Manhattan, KS) under the supervision of Pet Food and Ingredient Technology, Inc. 
(Topeka, KS). Dogs were offered 155 g of diet twice daily (0800 and 1700 h) to meet the required 
energy needs based on the estimated ME content of the diet. Food refusals were recorded daily, 
and fresh water was provided to the dogs ad libitum. Chromic oxide was added as a digestion 
marker but was not needed because of excellent stool quality and ease of fecal collection from the 
pen floor.   
Sample handling and processing 
 Total feces excreted during the collection phase of each period were taken from the pen 
floor, weighed, and frozen at -20°C until analysis. All fecal samples during the collection period 
were subjected to a consistency score according to the following scale: 1 = hard, dry pellets, small 
hard mass; 2 = hard, formed, dry stool; remains firm and soft; 3 = soft, formed, and moist stool, 
retains shape; 4 = soft, unformed stool, assumes shape of container; and 5 = watery, liquid that can 
be poured. 
Fecal samples were dried at 55°C in a forced-air oven and ground in a Wiley mill (model 
4, Thomas Scientific, Swedesboro, NJ) through a 2-mm screen. On d 11 of each period, fresh fecal 
samples were collected within 15 min of defecation. An aliquot of fresh feces was immediately 
transferred to sterile cryogenic vials (Nalgene, Rochester, NY) and snap-frozen in liquid nitrogen. 
Once frozen, vials were stored at -80°C until used for DNA extraction for microbial analysis. 
Aliquots for analysis of phenols, indoles, and biogenic amines were frozen at -20°C immediately 
after collection. One aliquot was collected and placed in approximately 2 mL of 2 N hydrochloric 
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 acid for ammonia, SCFA, and BCFA analyses. Additional aliquots were used for pH measurement 
and fresh fecal DM determination.  
Microbiome analysis 
Fecal DNA Extraction and 454 Pyrosequencing 
  Bacterial DNA was extracted according to McInnes and Cutting (2010) using the 
PowerSoilTM Kit (MO BIO Laboratories, Carlsbad, CA). Extracted DNA concentrations were 
quantified using a Qubit® 2.0 Fluorometer (Life Technologies, Carlsbad, CA) and diluted to 5 
ng/mL. Quality of DNA was assessed by electrophoresis using precast agarose gels (E-Gel® EX 
Gel 1%, Invitrogen, Grand Island, NY). Amplification of a 600-bp sequence of the V4–V6 variable 
region of the 16S rRNA gene was done using barcoded primers (Cephas et al., 2011). Amplicons 
from PCR then were purified further utilizing AMPure XP beads (Beckman-Coulter Inc., 
Indianapolis, IN). Amplicons were combined in equimolar ratios to create a DNA pool that was 
used for pyrosequencing. Quality of DNA from amplicon pools was assessed before 
pyrosequencing using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). 
Pyrosequencing was performed at the Roy J. Carver Biotechnology Center at the University of 
Illinois utilizing a 454 Genome Sequencer and FLX titanium reagents (Roche Applied Science, 
Indianapolis, IN). 
Bioinformatics 
High quality (quality value > 25) sequence data derived from the sequencing process was 
processed using a proprietary analysis pipeline (www.mrdnalab.com) and as described previously 
(Dowd et al., 2008a,b; Edgar, 2010; Capone et al., 2011; Dowd et al., 2011; Eren et al., 2011; 
Swanson et al., 2011) . Briefly, sequences were depleted of barcodes and primers, short sequences 
(< 200 bp), sequences with ambiguous base calls, and sequences with homopolymer runs 
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 exceeding 6 bp. Sequences then were denoised, and chimeras were removed. Operational 
taxonomic units (OTU) were defined after removal of singleton sequences and clustering at 3% 
divergence (97% similarity). Then, OTUs were taxonomically classified using BLASTn against a 
curated GreenGenes database (accessed January 2012) (DeSantis et al., 2006) and compiled into 
each taxonomic level into both “counts” and “percentage” files. Only genera and species that 
represented greater than 0.01% of the total sequences were reported. 
Statistical analysis  
Data were analyzed as a completely randomized design using the Mixed procedure of SAS 
(Version 9.2; SAS Institute, Inc., Cary, NC). The UNIVARIATE procedure was used to assure 
equal variance, normal distribution, and to identify outliers. Any observation that was more than 
three standard deviations away from the mean was considered an outlier. Data were transformed 
by log or square root if the normality assumption was not met. The in vitro experimental data were 
analyzed using mean separation with a Tukey’s adjustment to determine differences among 
substrates. For the in vivo dog experiment, diet was considered a fixed effect, whereas random 
effects included animal and period. Linear and quadratic effects were tested, using orthogonal 
polynomial contrasts. Differences among dietary treatments were determined using the least 
significant difference method. A probability of P < 0.05 was accepted as being statistically 
significant. Additionally, sequence percentages were compared using single degree of freedom 
orthogonal contrasts to test linear and quadratic effects of providing graded concentrations of 
dietary SCF, and all SCF treatments (0.5 to 1.25%) were compared with the 0% SCF control using 
a single degree of freedom contrast. Principal component analysis was used to assess shifts in 
variability between diets and Chao 1 and rarefaction curves were used to assess microbial diversity 
and species richness.  
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 Results 
Substrate chemical analysis  
Soluble corn fiber was devoid of crude protein and ash and had very low concentrations of 
acid-hydrolyzed fat (Table 3.1). It contained a high amount of total dietary fiber (78.3%) that was 
completely soluble. Starch concentration was 25.5% with a notable proportion of resistant starch 
7.8%. These values sum to 103.8% because a portion of the resistant starch was included in the 
TDF value. More low-molecular weight soluble fiber (55.5%) was present in SCF, as compared 
with high molecular weight soluble fiber (22.8%). The concentration of total free sugars was very 
low (28.5 mg/g DM), with glucose serving as the predominant free sugar (24.9 mg/g DM).  
In vitro hydrolytic digestion/fermentation 
 Concentrations of SCFA produced over time from cellulose, SCF, and pectin are shown in 
Figure 3.1. During the in vitro hydrolytic-enzymatic digestion, SCF was only 7% digestible (data 
not shown), leaving 93% as indigestible material for subsequent in vitro fermentation. Once 
hydrolytic-enzymatic digestion was complete, the fermentation experiment was corrected for the 
release of free sugars.   
Over the 12 h in vitro fermentation, a numerical decrease in pH due to concomitant 
increases (P < 0.05) in acetate, propionate, and butyrate concentrations with SCF was noted. 
Concentrations of acetate, propionate, and total SCFA were greater (P < 0.05) for SCF at each 
time-point compared with cellulose. Soluble corn fiber elicited higher (P < 0.05) butyrate 
concentrations at 6, 9, and 12 h compared with cellulose. In comparison with pectin, SCF produced 
lower (P < 0.05) acetate, propionate, butyrate, and total SCFA concentrations throughout the 12 h 
fermentation, which translated into less (P < 0.05) of a decrease in pH over time.  
In vivo experiments 
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  Rooster study: TMEn 
 The TMEn value was determined to be 2.6 kcal/g (Table 3.1).  
 Dog study 
Table 3.2 presents the ingredient composition of the basal diet fed to dogs, and Table 3.3 
presents the analyzed chemical composition of all experimental diets. All diets had similar DM, 
OM, CP, acid-hydrolyzed fat, TDF, and GE concentrations. During the feeding study, food intake 
was similar among treatments at 310 g/d as-is (288 g DM/d) and dogs consumed all of their food 
allotment (data not shown). Fecal output, apparent total tract nutrient digestibility, and fecal 
consistency scores are all presented in a supplementary table (Table 3.6). Briefly, fecal output and 
nutrient digestibility were not affected by increasing concentrations of dietary SCF. Fecal 
consistency was excellent across all diets, and no differences due to dietary treatment were 
observed.  
 Table 3.4 presents fecal SCFA, BCFA, and ammonia concentrations, as well as fecal pH 
values, for dogs. Fecal concentrations of acetate, propionate, and total SCFA were lowest (P < 
0.05) when dogs were fed the 0.75% SCF diet. When compared with the 0.75% SCF diet, dogs 
fed 1.25% SCF had higher (P < 0.05) fecal acetate, propionate, and total SCFA concentrations. 
Fecal butyrate concentrations were not affected by treatment. Fecal BCFA and ammonia 
concentrations were low and showed no significant differences due to treatment. Other markers of 
protein fermentation, including phenols, indoles, and biogenic amines, were measured; however, 
these compounds were present at low concentrations and were not affected by dietary SCF 
concentration (data not shown).  
Pyrosequencing of 16S rRNA gene-barcoded amplicons resulted in a total of 769,200 
sequences, with an average of 15,384 reads (range: 8,776 to 32,349) per sample. Samples had an 
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 average read length of 506 base-pairs. According to Chao 1 values and rarefaction curves (data 
not shown), microbial diversity and species richness were similar among dietary treatments. 
Principal component analysis revealed no separation among dietary treatments (data not shown). 
Regardless of dietary treatment, Firmicutes (24.78 to 92.69% of all sequences) was the 
predominant bacterial phylum in dog feces, followed by Fusobacteria (0.11 to 52.21% of all 
sequences) and Tenericutes (2.58 to 54.04% of all sequences; Table 3.5). Actinobacteria (0 to 
9.68% of all sequences), Bacteroidetes (0 to 3.22% of all sequences), and Proteobacteria (0 to 
8.41% of all sequences) were also present. No statistically significant changes were noted among 
treatments, but there was a numeric increase in the proportions of Firmicutes and a numeric 
decrease in Fusobacteria with SCF supplementation. 
 Fusobacterium (0.11 to 52.21% of all sequences), Clostridium (7.31 to 53.29% of all 
sequences), Blautia (4.38 to 34.04% of all sequences), and Allobaculum (0.27 to 53.58% of all 
sequences) were the predominant genera in dog feces (Table 3.5).Fecal Lachnospira increased (P 
< 0.05) with increasing concentrations of dietary SCF.  The proportions of Roseburia and 
Ruminococcus decreased (P < 0.05) linearly with increasing concentrations of SCF. Within the 
Tenericutes phylum, the proportion of Catenibacterium increased linearly (P < 0.05) with 
increasing SCF concentrations. Fecal Coprobacillus exhibited a linear decrease (P < 0.05) and, 
overall, dogs fed diets containing SCF had lower (P < 0.05) Coprobacillus compared with dogs 
fed the 0% SCF diet. Bacterial populations at the species level are presented as supplementary 
material (Table 3.7).  
Discussion 
Functional food ingredients that are becoming increasingly popular include low digestible 
carbohydrates that induce prebiotic effects. Prebiotics are defined as non-digestible food 
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 ingredients that, when consumed in sufficient amounts, selectively stimulate the growth, activity 
or both of one or a limited number of microbial genera or species in the gut microbiota that 
ultimately benefits health of the host (Tremaroli and Backhed, 2012). Common prebiotic fibers 
present in companion animal and human foods include fructooligosaccharides, inulin, and resistant 
starch (Tomasik and Tomasik, 2003). Low digestible carbohydrates often are low-molecular 
weight and resist mammalian hydrolytic/enzymatic digestion, and will enter the large bowel to be 
fermented by microbes to produce SCFA and lower digesta pH (Mussato and Manchilha, 2007). 
They are similar to dietary fiber in that they have the ability to provide health-promoting effects 
on the host (Knapp et al., 2010).  
Soluble corn fiber contained 78% total dietary fiber, all of which was soluble fiber, with 
55% in a low molecular weight form. Soluble corn fiber is a purified fiber source having no or 
very low concentrations of ash, CP, AHF, and free sugars, and a moderate amount of both 
digestible and type-4 resistant starch. The SCF used in this study was a soluble fiber dextrin 
derived from corn starch that is considered a low digestible carbohydrate due to its high proportion 
of low-molecular weight soluble fiber.  Normally, corn starch is made up of α-1,4 and α-1,6 
glycosidic bonds that are easily degraded by mammalian pancreatic amylase. The dextrinization 
process uses heat and acid to hydrolyze the α-glycosidic bonds. Upon cooling, the reformation of 
both digestible glycosidic bonds (α-1,4 and α-1,6), as well as non-digestible glycosidic bonds (β-
1,4, 1,6, 1,3, and 1,2), make up the short-chain oligosaccharides that then can enter the large bowel 
for fermentation by the resident microbiota (Knapp et al., 2010). Previous studies have shown that 
SCF is a good candidate for low energy and low glycemic dog diets (de Godoy et al., 2013), but 
no information was available regarding prebiotic potential of SCF fed to dogs.  
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 The in vitro hydrolytic-enzymatic digestion experiment suggested that SCF was only 7% 
digestible, leaving 93% of the substrate available for fermentation. The SCF was highly 
fermentable throughout the entire 12 h fermentation, exhibiting increases in SCFA concentrations 
at each time point. Wheat dextrin soluble fiber (NUTRIOSE®FB06) was tested for in vitro 
fermentation properties using human fecal inoculum (Hobden et al., 2013). In that study, acetate, 
propionate, and butyrate were reported to increase in the distal portion of the gut model compared 
with the proximal portion, indicating that the wheat dextrin soluble fiber substrate was potentially 
fermentable throughout the gastrointestinal tract. Furthermore, wheat dextrin soluble fiber 
modulated the microbiota in the model, with increases in butyrate-producing taxa (Hobden et al., 
2013). Knapp et al. (2010) determined that a variety of soluble fiber dextrins, including those 
derived from corn starch, may be potential substrates for hindgut fermentation due to their ability 
to resist in vitro hydrolytic-enzymatic digestion. This was supported further by low glycemic 
responses in dogs (Knapp et al., 2010).  
Previous studies that have determined TMEn values of various SCF substrates that were 
obtained by different methods of starch hydrolysis reported values as low as 1.7 kcal (Knapp et 
al., 2010) and as high as 3.0 kcal (de Godoy et al., 2014). Our TMEn value of 2.6 kcal/g is accurate 
since the SCF used in this study was treated with hydrochloric acid and was consistent with the 
TMEn value obtained previously using the same processing method (2.4 kcal/g) (de Godoy et al., 
2014). The variation in TMEn values of different SCF substrates has been attributed to differences 
in processing methods and molecular structures of the carbohydrates (de Godoy et al., 2014).  
  Nutrient digestibility was not affected by SCF inclusion in this study, and there were no 
significant changes in fecal SCFA concentrations, fecal pH, or fecal consistency relative to the 0% 
SCF diet. Similarly, we observed no changes in markers of protein fermentation as evidenced by 
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 a lack of change in fecal BCFA, phenolic and indolic compounds, and biogenic amines with 
increasing SCF supplementation. Higher dietary concentrations of SCF than those used here may 
be necessary to affect these outcomes. Dogs may also have a lower ability to ferment the SCF 
substrate compared to humans, perhaps due to differences in abundance of select microbial taxa 
(i.e. Firmicutes, Fusobacteria, Bacteroidetes, Proteobacteria and Actinobacteria), volume of the 
large bowel, and anatomical/physiological differences, such as sacculations and transit time.  
Previous in vivo studies in rodent and human models investigating dietary SCF determined 
this substrate to be highly fermentable (defined by SCFA concentration), modulators of the 
microbiome, and overall favorable to indices of gut health. The objectives of these studies, 
however, were to determine the efficacy of dietary SCF as a fermentable fiber source. Therefore, 
the concentrations of SCF added to the diet were high to elicit these responses. Normally, prebiotic 
fibers are added at low concentrations in the diet to increase SCFA concentrations and stimulate 
the growth of potentially beneficial bacteria. The objective of this current study was to assess the 
prebiotic potential of SCF, which entails adding graded concentrations of SCF of only up to 1.25% 
of the diet. The previous in vivo studies in humans and rodents have shown the potential health 
benefits of SCF as a fiber source at higher dietary concentrations. Dietary SCF concentrations of 
5% or higher in rats has been found to improve cecal and colonic fermentation characteristics, as 
well as indices of gut health (i.e., increased crypt depth, goblet cell numbers, and acidic mucins) 
(Guerin-Deremaux et al., 2010; Knapp et al., 2013). Similarly, in humans, consumption of SCF at 
20 g/d resulted in a decrease in colonic pH, suggesting increased fermentative activity (Lefranc-
Millot et al., 2012).  
In recent years, the development of novel high-throughput sequencing techniques has led 
to a more comprehensive understanding of the microbial populations present in the colon. 
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 Specifically, the effect of diet on the microbial populations, as well as their functional capacity to 
metabolize nutrients, can be measured using these techniques. Very limited research using these 
techniques has been conducted with dietary SCF. In humans, consumption of 21 g/d of SCF 
elicited increases in select butyrate-producing taxa (i.e., Faecalibacterium spp. and 
Facaelibacterium prausnitzii), as well as increases in lactobacilli (Hooda et al., 2012).  
In our study, there were no significant differences in the diversity of gut bacteria among 
diets, nor was there a clear clustering by diet as indicated by principal component analysis. The 
predominant bacterial phyla present in feces of dogs fed all diets in this study were Firmicutes and 
Fusobacteria. Previously published data showed that a normal dog fecal microbiome was variable, 
with studies showing 14 to 48% Firmicutes and 7 to 40% Fusobacteria (Middelbos et al., 2010; 
Suchodolski et al., 2008; Swanson et al., 2011). At the microbial genus level, there was only slight 
modulation of the fecal microbiome with increasing dietary SCF. Dogs fed the 1% SCF diet 
showed increases in Lachnospira, which is a part of the butyrate-producing superfamily 
Lachnospiraceae (Marounek and Duskova 2002). However, this did not translate into increases in 
fecal butyrate concentrations.  
Previous studies in humans have suggested that SCF and other fibers similar in chemical 
composition (e.g. wheat dextrin soluble fiber) are fermentable in vitro and in vivo and can 
beneficially modulate the microbiome, but these effects were observed only at dietary 
concentrations well above the highest concentration used in the present study (Pasman et al., 2006; 
Lefranc-Millot et al., 2012; Hobden et al., 2013). The integration of both in vitro fermentation and 
in vivo dog data suggests that SCF elicits some modulation of the microbiome; however, the doses 
provided were insufficient to induce a robust response.  
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 Soluble corn fiber added at concentrations similar to proven prebiotics did not elicit the 
same effects on SCFA concentration, pH decline, or shifts in the microbial populations in dogs. 
Prebiotic fibers such as fructooligosaccharides and galactooligosaccharides are effective at all of 
the dietary concentrations tested in this experiment, putting this particular novel fiber at a 
disadvantage because of the higher concentrations that ostensibly would be required to elicit an 
effect. Overall, establishing an effective dose of SCF to elicit effects of increased SCFA 
concentrations, modulation of the microbiome, and other indices of gut health is needed.  
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Table 3.1. Chemical composition of soluble corn fiber 
Item Concentration 
 Dry matter, %   96.5 
------------ dry matter basis ------------- 
 Organic matter, %                 100.0 
 Crude protein, %    0.0 
 Acid-hydrolyzed fat, %    0.5 
 Total dietary fiber, %  78.3 
   Insoluble dietary fiber    0.0 
   Soluble dietary fiber  78.3 
     HMWSF1   22.8 
     LMWSF2   55.5 
Starch, %  
  Digestible                   17.7 
  Resistant                     7.8 
  Total                   25.5 
Free sugars, mg/g  
  Arabinose   0.7 
  Galactose   0.3 
  Glucose                  24.9 
  Sucrose  0.7 
  Mannose  0.1 
  Fructose  1.8 
  Total                  28.5 
Gross energy, kcal/g  4.1 
TMEn3, kcal/g  2.6 
1High molecular weight soluble fiber defined as the 
portion that precipitated in 95% ethanol. 
2Low molecular weight soluble fiber defined as the 
portion that did not precipitate in 95% ethanol. 
3Nitrogen corrected true ME. 
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Table 3.2. Ingredient composition of the basal diet fed to dogs1 
Ingredient  % as-fed 
  Brewer's rice                            46.55 
  Poultry byproduct meal-low ash           25.50 
  Corn, yellow, ground                     12.00 
  Poultry fat                                8.00 
  Soluble corn fiber2                           Variable 
  Cellulose3    6.00 
  Salt                                       0.70 
  Potassium chloride                         0.56 
  Chromic oxide                              0.20 
  Mineral mix4    0.18 
  Vitamin mix5    0.18 
  Choline chloride-50%                       0.13 
1Soluble corn fiber was added at 0, 0.5, 0.75, 1.0, or 1.25% of 
the diet at the expense of cellulose and brewer’s rice to main 
isofibrous and isonitrogenous diets. 
2 NUTRIOSE®FM:  Roquette;. Lestrem, France. 
3Cellulose: Solka-Floc, International Fiber Corp., North 
Tonawanda, NY. 
4Provided per kilogram of diet: Mn (as MnSO4), 66.00 mg; Fe 
(as FeSO4), 120 mg; Cu (as CuSO4), 18 mg; Co (as CoSO4), 
1.20 mg; Zn (as ZnSO4), 240 mg; I (as KI), 1.8 mg; Se (as 
Na2SeO3), 0.24 mg. 
4Provided per kilogram of diet: vitamin A, 5.28 mg; vitamin 
D3, 0.04 mg; vitamin E, 120 mg; vitamin K, 0.88 mg; thiamine, 
4.40 mg; riboflavin, 5.72 mg; pantothenic acid, 22.00 mg; 
niacin, 39.60 mg; pyridoxine, 3.52 mg; biotin, 0.13 mg; folic 
acid, 0.44 mg; vitamin B12, 0.11 mg. 
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Table 3.3. Chemical composition of experimental diets fed to dogs. 
 % Soluble corn fiber 
Item 0  0.5  0.75    1.0        1.25 
  Dry matter, %    92.9      92.7      93.4      92.9        93.2 
                                                 ------------------ % dry matter basis -------------------- 
  Organic matter    94.5      94.6      94.5      94.2        94.1 
  Crude protein    23.4      23.8      24.2      24.3        24.9 
  Acid-hydrolyzed fat    14.1      13.8      13.7      14.0        14.0 
  Total dietary fiber    7.34      7.38      7.39      7.43        7.44 
  GE, kcal · g-1     4.99      4.98      4.98      5.00        4.99 
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Table 3.4. Fecal short-chain fatty acid (SCFA), branched-chain fatty acid (BCFA), and ammonia concentrations, and pH 
values for dogs fed diets containing graded soluble corn fiber concentrations 
 % Soluble corn fiber   P -value 
Item  0 0.5 0.75 1 1.25 SEM P-value Linear Quadratic 
pH    6.67    6.45    6.47    6.62    6.23       0.13 0.11       0.09      0.73 
SCFA, µmol/g DM           
  Acetate 268.7ab  313.6ab  254.7a  292.2ab 317.2b       17.1 0.02       0.15      0.58 
  Propionate   96.7ab  116.5b    91.8a  111.9ab 118.9b         7.5 0.01       0.09      0.64 
  Butyrate   53.8    57.8    44.8    48.9   53.8         6.1 0.19       0.98      0.79 
  Total  419.2ab  487.9b  391.3a  453.1ab 490.0b       27.6 0.02       0.21      0.57 
BCFA, µmol/g DM          
  Isobutyrate   8.34    9.00    7.72    8.23   8.14       0.71 0.51       0.66      0.86 
  Isovalerate 12.93  14.63  12.44  13.27 13.16       1.23 0.10       0.22      0.77 
  Valerate    0.87    0.94    0.84    0.82   1.04       0.15 0.63       0.65      0.62 
  Total 22.13  24.96  21.00  22.32 22.34       2.01 0.53       0.85      0.79 
Ammonia, µmol/g DM 176.1  194.9  162.4  178.8 177.9     13.94 0.22       0.80      0.91 
abMean values within a row with unlike superscript letters differ (P < 0.05). 
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Table 3.5. Predominant bacterial phyla and genera expressed as a percentage of total sequences in feces of dogs fed diets containing graded 
soluble corn fiber concentrations1 
   % Soluble corn fiber   
Phylum Family Genus   0       0.5 0.75        1     1.25 SEM P-value 
Actinobacteria   0.26  0.34  0.33  0.17 0.36 0.21 0.74 
 Bifidobacteriaceae Bifidobacterium 0.24  0.32  0.31  0.15 0.34 0.21 0.73 
Bacteroidetes   1.00  0.56  0.91  0.68 0.71 0.21 0.44 
 Bacteroidaceae Bacteroides 0.49  0.28  0.31  0.47 0.38 0.08 0.08 
 Prevotellaceae Prevotella 0.34  0.26  0.46  0.41 0.31 0.19 0.91 
Firmicutes    56.94   56.44  59.06   59.26  64.89 5.30 0.40 
 Acidaminococcaceae Acidaminococcus    0.22  0.22  0.27  0.32 0.18 0.05 0.35 
 Clostridiaceae Clostridium  24.73   21.81  25.17   22.34  26.54 3.87 0.54 
 Eubacteriaceae Eubacterium 1.41  2.07  2.08  1.63 3.08 0.83 0.21 
 Lachnospiraceae Blautia  10.97   12.80  14.09   12.71  15.15 2.23 0.34 
  Dorea 0.24  0.08  0.08  0.25  0.04 0.08 0.08 
  Lachnospira  0.02a    0.92ab   1.52b   1.57b    1.51b 0.42 0.01 
  Roseburia* 0.69  0.56  0.54  0.50  0.35 0.14 0.23 
 Lactobacillaceae Lactobacillus 3.38  4.92  2.75  4.20  5.88 2.86 0.49 
 Paenibacillaceae Paenibacillus 0.19  0.25  0.37  0.18  0.39 0.14 0.47 
 Peptococcaceae Delsulfotomaculum 0.75  1.00  1.68  0.75  1.42 0.59 0.39 
 Ruminococcaceae Faecalibacterium 2.79  3.64  2.43  3.15  5.50 0.97 0.20 
  Oscillospira 0.79  0.82  0.62  1.11  0.66 0.30 0.35 
  Ruminococcus* 5.64  5.06  3.96  5.00  4.12 1.04 0.13 
 Turcibacteraceae Turicibacter 0.54  0.59  1.23  0.98  1.39 0.48 0.55 
 Veillonellaceae Megamonas† 1.27  0.69  1.13  0.90  1.80 0.32 0.06 
  Phascolarctobacterium 4.90  4.38  4.86  6.97  4.05 1.05 0.15 
Fusobacteria    28.37   27.05  23.69   28.69   17.70 4.52 0.20 
 Fusobacteriaceae Fusobacterium  28.37   27.05  23.69   28.69 17.70 4.52 0.20 
Proteobacteria      2.67  1.92  1.86  2.72  2.61 0.68 0.13 
 Succinivibrionaceae Succinivibrio    0.16  0.09  0.12  0.08  0.25 0.08 0.20 
  Anaerobiospirillum    0.22  0.38  0.14  0.57  0.17 0.18 0.22 
 Alicaligenaceae Sutterella    1.99  1.31  1.45  1.76  1.12 0.47 0.28 
Tenericutes    10.75   12.75  14.14   10.78  14.06 4.10 0.32 
 Erysipelotrichaceae Allobaculum 7.71  9.20  10.32  4.74  8.13 3.96 0.12 
  Bulleidia 0.32  0.22  0.35  0.18  0.26 0.11 0.62 
  Catenibacterium* 0.14     0.26  0.16  0.24  1.33 0.39 0.08 
  Coprobacillus‡* 0.33b   0.17a 0.19ab    0.25ab   0.14a 0.05 0.01 
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Table 3.5 continued. Predominant bacterial phyla and genera expressed as a percentage of total sequences in feces of dogs fed diets containing 
graded soluble corn fiber concentrations1 
1Genera included have least squares means of 0.01 or higher. 
abMean values in the same row with unlike superscript letters differ (P < 0.05). 
‡ Difference between 0% SCF vs. all other SCF diets (P < 0.05). 
*Linear effect (P < 0.05). 
†Quadratic effect (P < 0.05). 
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Table 3.6. Nutrient digestibility and fecal scores from dogs fed diets containing graded soluble corn fiber concentrations1 
 % Soluble corn fiber   P-value 
Item  0 0.5  0.75 1 1.25 SEM P-value Linear Quadratic 
Feed intake, g/d DM  287.9 287.4 289.4  288.0   288.8        
Fecal output, g          
  As-is  597.4 609.1 573.4  571.2   592.5    23.4 0.75 0.53 0.81 
  Dry matter basis  223.1 220.6 212.0  210.9   211.9 7.41 0.67 0.17 0.84 
Fecal DM, %     37.5    36.2   37.1    37.0     36.0 0.70 0.05 0.27 0.98 
Apparent total tract digestibility, %          
  Dry matter    80.6   80.8   81.7    81.7     81.7   0.64 0.61 0.15 0.84 
  Organic matter    83.3   83.5   84.3    84.5     84.2   0.57 0.49 0.12 0.80 
  Crude protein    81.7   81.3   80.7    80.2     80.2   0.84 0.31 0.22 0.76 
  Acid hydrolyzed fat    94.2   94.2   94.7    94.4     94.7   0.31 0.36 0.17 0.87 
  Energy    84.4   84.3   85.2    85.3     85.0   0.58 0.66 0.24 0.86 
Digestible energy intake, kcal·d-1   1213  1206  1228   1230    1224   8.39 0.23 0.12 0.95 
Fecal score      2.6     2.6     2.4      2.6       2.7   0.12 0.17 0.79 0.37 
1Values expressed on a dry matter basis. 
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Table 3.7. Predominant bacterial species expressed as a percentage of total sequences in feces of dogs fed diets 
containing graded soluble corn fiber concentrations1 
 % Soluble corn fiber   
Species 0  0.5   0.75       1    1.25 SEM P-Value 
Acidaminococcus intestini    0.22    0.22   0.27    0.32   0.18 0.05 0.35 
Allobaculum sp id4    4.64    4.31   4.41    3.84   3.86 3.87 0.63 
A.stercoricanis    3.07    4.89   5.91    3.20   4.27 1.08 0.28 
Anaerobiospirillum succiniciproducens    0.22    0.38   0.14    0.57   0.17 0.18 0.28 
Anaerotruncus colihominis    0.06    0.06   0.05    0.07   0.04 0.02 0.72 
Bacteroides cellulosilyticus‡*    0.09    0.04   0.06    0.05   0.04 0.02 0.11 
B. coprocola*    0.03a    0.03a   0.05ab    0.07ab   0.10b 0.02 0.02 
B. eggerthii    0.11    0.09   0.08    0.15   0.09 0.02 0.13 
B. plebeius    0.14    0.06   0.12    0.08   0.08 0.03 0.20 
Bifidobacterium pseudolongum    0.23    0.85   0.28    0.12   0.95 0.48 0.44 
B. hydrogenotrophica    0.12    0.14   0.25    0.08   0.25 0.10 0.28 
Blautia producta‡*    9.85  12.00 13.06  11.92 13.95 2.05 0.23 
B. ruminococcus obeum†    1.01    0.65   0.79    0.71   0.95 0.17 0.32 
Catenibacterium mitsuokai    0.14    0.26   0.16    0.24   0.20 0.10 0.29 
Clostridium bartlettii    0.30    0.25   0.38    0.38   0.51 0.12 0.53 
C. bifermentans    0.17    0.19   0.22    0.15   0.08 0.08 0.55 
C. bolteae    0.23    0.28   0.20    0.32   0.27 0.07 0.55 
C. cocleatum    0.17    0.11   0.08    0.12   0.12 0.07 0.82 
C. hathewayi    0.37    0.33   0.20    0.32   0.36 0.07 0.15 
C. hiranonis  21.42  18.74 22.14  18.74 22.95 3.62 0.54 
C. methoxybenzovorans    0.05    0.08   0.04    0.04   0.05 0.01 0.09 
C. perfringens    0.17    0.11   0.01    0.03   0.11 0.08 0.43 
C. ramosum    0.13    0.34   0.27    0.27   0.26 0.15 0.80 
C. spiroforme    0.91    0.63   0.72    1.09   0.99 0.32 0.43 
C. thermosuccinogenes    0.09    0.14   0.11    0.15   0.19 0.06 0.60 
C. xylanolyticum    0.08    0.11   0.05    0.07   0.06 0.02 0.13 
Coprobacillus cateniformis‡*    0.33b   0.17ab   0.19a    0.25ab   0.14a 0.05      0.01 
Coprococcus catus    0.04a    0.08b   0.02a    0.05ab   0.03a 0.01      0.01 
Desulfotomaculum halophilum    0.74    0.98   1.65    0.74   1.38 0.58 0.55 
Dorea formicigenerans‡*    0.20b    0.08ab   0.06a    0.11ab   0.04a 0.05 0.01 
Eubacterium dolichum    0.09    0.08   0.07    0.09   0.05 0.04 0.42 
E. biforme‡*    0.58a    1.60a   1.48a    1.12a   2.44b 0.77 0.08 
E. sulci    0.44    0.31   0.42    0.37   0.34 0.15 0.84 
Faecalibacterium prausnitzii      2.79    3.64   2.43    3.15   5.50 0.97 0.20 
Fusobacterium mortiferum‡      7.68    3.76   2.97   4.89   2.70 1.57 0.13 
F. varium    20.52  23.21 20.64 23.68 14.92 3.76 0.25 
Lactobacillus acidophilus      0.00    0.01   0.05    0.27   0.42 0.20 0.48 
L. apodemi      0.03    0.03   0.05    0.05   0.17 0.05 0.32 
L. johnsonii      2.56    3.05   1.45    2.45   0.36 1.70 0.50 
L. lactococcus lactis      0.31    0.47   0.34    1.00   1.84 0.67 0.47 
L. reuteri      0.05    0.12   0.10    0.04   0.03 0.06 0.64 
L. reuteri (strain F275)      0.41    0.31   0.72    0.39   0.32 0.32 0.72 
Megamonas hypermegale†     1.27ab    0.69a   1.13ab    0.90ab   1.80b 0.32 0.06 
Paenibacillus borealis      0.17    0.24   0.35    0.17   0.20 0.10 0.39 
Prevotella copri      0.34    0.26   0.46    0.41   0.31 0.19 0.95 
Roseburia eubacterium rectale      0.67    0.53   0.49    0.73   0.32 0.17      0.18 
Ruminococcus flavefaciens      0.48    0.58   0.44    0.58   0.46  0.12      0.77 
R. gnavus‡      3.40    2.14   2.22    2.94   2.16 0.88      0.15 
R. torques     1.76ab    2.33b   1.30a    1.46ab   1.49ab 0.35      0.02 
Sutterella sanguinus      0.46    0.29   0.50    0.47   0.44 0.17      0.73 
S. stercoricanis      0.15    0.08   0.13    0.15   0.10 0.04      0.44 
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Table 3.7 continued. Predominant bacterial species expressed as a percentage of total sequences in feces of dogs 
fed diets containing graded soluble corn fiber concentrations1 
abMean values in the same row with unlike superscript letters differ (P < 0.05). 
‡ Difference between 0% NU vs. other diets (P < 0.05).  
*Linear effect (P < 0.05). 
†Quadratic effect (P <0.05). 
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Figure 3.1. In vitro experiment: concentrations of acetate (A), propionate (B), butyrate 
(C), and total short-chain fatty acids (SCFA) (D), and pH values during a 12 h in vitro 
fermentation. Standard error bars are presented for each mean value.* denotes a 
significant (P < 0.05) time by treatment interaction. # denotes a significant difference 
(P < 0.05) between pectin and SCF within each time point. 
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 CHAPTER 4: MODERATELY FERMENTABLE POTATO FIBER ATTENUATES 
BODY WEIGHT LOSS AND IS ANTI-INFLAMMATORY DURING EXPERIMENTAL 
COLITIS  
Abstract 
 Potato fiber (PF), a co-product of potato starch isolation, is a moderately fermentable (30-
70% fermentable) dietary fiber that was evaluated for its efficacy in attenuating the acute 
inflammatory response in a dextran sodium sulfate (DSS)-induced colitis mouse model. We 
hypothesized that dietary PF would attenuate the inflammatory response more effectively than 
non-fermentable cellulose (Cell) due, in part, to the influence of fermentation end-products (i.e., 
short-chain fatty acids; SCFA). Male C57Bl/6J mice (n=67) were randomized based on initial body 
weight to diets containing either 8% Cell (n=34) or 14.5% PF (n=33) for a 22-d feeding study. 
Starting on study d 14, mice were provided either distilled water or 2% (wt/vol) DSS in drinking 
water for 5 d, after which all mice received distilled water until study termination. Daily weights 
of mice, food, and water were collected from d 14 through d 22. Distal colon tissue was analyzed 
for histological outcomes and changes in gene expression, and cecal contents were analyzed for 
SCFA concentrations. All data were analyzed by ANOVA with repeated measures analyses 
applied where necessary. Mice provided the PF/DSS treatment exhibited a delayed (P < 0.05) loss 
in body weight compared with mice provided the Cell/DSS treatment following DSS 
administration. Furthermore, by study end (d 8 post-DSS administration), mice on the PF/DSS 
treatment exhibited earlier recovery from body weight loss (P < 0.05) compared with Cell/DSS 
mice. A diet by DSS treatment interaction (P < 0.05) was noted for cecal SCFA concentrations, 
which were higher in the PF/DSS treatment compared with the Cell/DSS treatment. This evidence 
was corroborated by positive changes in histology scores, with PF/DSS-treated mice exhibiting 
85 
 
 lower (P < 0.05) infiltration of leukocytes into the lamina propria compared with Cell/DSS-treated 
mice. The PF/DSS treatment also decreased (P < 0.05) mRNA expression of distal colon 
inflammatory cytokines TNF-α, IL1-β, IL-6, and IL-17A, as well as the potent neutrophil 
chemoattractant chemokine, CXCL1, compared with the Cell/DSS treatment. These results 
suggest that ingestion of PF during chemically-induced experimental colitis may attenuate the 
inflammatory response through microbial production of SCFA.  
Introduction 
Ulcerative colitis and Crohn’s disease are both inflammatory bowel diseases (IBD) that are 
marked by intermittent bouts of inflammation throughout the gastrointestinal tract (Goto et al., 
2010). The etiology of IBD is not fully understood; however, there are known genetic, 
immunologic, and environmental factors (Pillai et al., 2013). The human intestine is enumerated 
with 1013 to 1014 microorganisms that have the ability to metabolize non-digestible carbohydrates 
(i.e., dietary fiber) and produce fermentative end-products, mainly the short-chain fatty acids 
(SCFA), acetate, propionate, and butyrate (Gill et al., 2006). Microbes residing in the human colon 
and increases their fermentative end-products (acetate, propionate, and butyrate), have been 
associated with diseases such as diabetes mellitus, obesity, IBD, and others (Turnbaugh et al., 
2009; Larson et al., 2010; Kranich et al., 2011). Interest in using dietary fiber to improve overall 
health has increased with new insights into the beneficial effects of the microbiome and, in 
particular, their ability to produce SCFA.  
Potato fiber (PF) is a co-product of potato starch isolation that has a chemical composition 
of fiber components (e.g., hemicelluloses, cellulose, and pectins) that are favorable to colonic 
fermentation (Mayer, 1998). Previous research in our lab using dogs suggested that PF is 
moderately fermentable, exhibiting dose-dependent linear increases in fecal acetate, propionate, 
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 and butyrate concentrations (Panasevich et al., 2013). Furthermore, with increasing concentrations 
of PF, we found shifts in the fecal microbiome of key SCFA-producing bacteria, and, in particular, 
butyrate producers (Panasevich et al., 2014). To this end, Faecalibacterium, and, more 
specifically, Faecalibacterium prausnitzii, a well-characterized butyrate-producing species, was 
increased by feeding graded dietary levels of PF to dogs. This bacterial species often is found in 
low concentrations in humans and dogs exhibiting IBD. These previous results led us to investigate 
whether PF, with its in vivo fermentation characteristics and ability to modulate the microbiome, 
would be efficacious in attenuating the inflammatory response in an animal model of ulcerative 
colitis.   
Our main objective in this study was to utilize a model of acute colitis, induced by oral 
dextran sodium sulfate (DSS), to test the efficacy of moderately fermentable PF in attenuating the 
inflammatory response. Dextran sodium sulfate dissolved in drinking water and provided ad 
libitum to mice has been used extensively as an animal model for IBD (Okayasu et al., 1990). Our 
study investigated diets containing identical concentrations of dietary fiber from two different 
sources; PF, which is moderately fermentable, and cellulose (Cell), which is an inert, non-
fermentable dietary fiber. We hypothesized that ingestion of PF would (1) ameliorate symptoms 
associated with DSS-colitis more effectively than Cell, and (2) SCFA concentrations would 
explain the anti-inflammatory effects during DSS colitis.   
Materials and Methods 
Animals and diets 
Male C57Bl/6J mice (8-10 weeks of age) were purchased from Jackson Laboratories (Bar 
Harbor, ME) and singly housed in a temperature-controlled room. Animals were provided ad 
libitum access to food and water throughout the study and housed under a reversed light cycle 
87 
 
 (lights on at 2100, lights off at 0900). Mice were acclimated to the facility and provided a standard 
AIN93G diet (5% fiber) (LabDiet/TestDiet; St. Louis, MO) for 14 d prior to starting the 
experimental diets. Following acclimation, mice were provided a modified AIN93G (8% total 
dietary fiber (TDF)) containing either a Cell (n=34) or PF (n=33) in the diet for a 22 d experimental 
feeding period. Each diet was formulated to be isofibrous (8% TDF), isonitrogenous, and 
isocaloric on the basis of the guaranteed analysis provided by the manufacturer, thereby applying 
experimental focus strictly on fermentability of the dietary fiber source. Potato fiber was added at 
14.5% of the diet to achieve an 8% TDF at the expense of corn starch to achieve equal 
concentrations of carbohydrate between diets.  
After receiving the experimental diets for 14 d, mice within each diet group were randomly 
assigned to receive either distilled water (Cell, n=17; PF, n=16) or DSS (Cell, n=17; PF, n=16) 
dissolved in drinking water for 5 d, after which time all mice then received distilled water until 
study end. Mice were euthanized 8 d after initiating water treatments, at which point tissues were 
collected. All corncob bedding and cages were sterilized before use and were changed weekly. All 
experiments were approved by the University of Illinois at Urbana-Champaign Institutional 
Animal Care and Use Committee. 
DSS treatment 
Dextran sodium sulfate was provided at a concentration and duration that would induce an 
acute inflammatory response (Perše and Cerar, 2012; Cook et al., 2013). Briefly, regular drinking 
water was replaced by 2% (wt/vol) DSS (MP Biochemicals; Santa Ana, CA; 36,000–50,000 MW) 
in sterile water for a 5 d period. The DSS solution was monitored daily, refilled appropriately, and 
replaced on d 3 after initial administration. On d 5 post-water treatment induction, all mice were 
provided distilled water until the study conclusion.  
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 Morbidity and tissue collection 
Mouse body weights were recorded upon arrival and once weekly until DSS was 
administered. Daily measurements of body weight and food and water intake were recorded during 
and after DSS administration. Mouse feces were evaluated in an observer-blinded manner for 
consistency/diarrhea (e.g., formed pellet vs. semi-formed/soft). Home-cage physical activity was 
assessed using a 4-point scale (1 = normal, 2 = slight reduction, 3 = limited, 4 = immobile), and 
response to capture using a 3-point scale (1 = normal evasion, 2 = some evasion, 3 = no evasion), 
as indicators of sickness behavior. 
Eight days after initiating water treatments, mice were euthanized by CO2 asphyxiation, 
and blood was collected into a heparin-coated tube by cardiac puncture and stored on ice. Plasma 
was separated and stored at −80°C. Whole ceca were excised and weighed with contents. The 
colon was removed (distal to the cecum extending to the anus) and colon length was assessed using 
digital calipers (Tresna©; Guilin, China) to the nearest mm. Mesentery tissue was removed from 
the colon, which was subsequently flushed with PBS and separated into proximal and distal 
sections. A 2-cm segment was cut from the top portion of the distal section, fixed in 10% buffered 
formalin for 24 h, and switched to 70% ethanol until sectioned for histological analysis. Additional 
samples of distal colon tissue were collected and stored at −80°C until analysis. 
Short-chain fatty acid analysis 
Cecal SCFA concentrations were determined according to Panasevich et al. (2013). 
Briefly, SCFA concentrations were determined by gas chromatography according to Erwin et al. 
(1961) using a gas chromatograph (Hewlett-Packard 5890A Series II, Palo Alto, CA) and a glass 
column (180 cm × 4 mm i.d.), packed with 10% SP-1200/1% H3PO4 on 80/100 + mesh 
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 Chromosorb WAW (Supelco Inc., Bellefonte, PA). Nitrogen was the carrier gas with a flow rate 
of 75 mL/min. Oven, detector, and injector temperatures were 125, 175, and 180°C, respectively.  
Histology 
Formalin-fixed distal colon samples were paraffin embedded, and 3 μm sections were 
stained with hematoxylin and eosin. Colon damage (i.e., necrosis) and immune cell infiltration 
were scored by a blinded observer based on a published scoring system that considers architectural 
derangements, goblet cell depletion, edema/ulceration, and degree of inflammatory cell infiltration 
(Wirtz et al., 2007). Each sample was ranked twice, once for necrosis and once for inflammation. 
Scoring for inflammatory cell infiltration was as follows: 0 = normal, 1 = mild, 2 = moderate, 3 = 
severe. Necrosis was scored as: 0 = normal, 1 = mild (∼1–25% necrotic), 2 = moderate (∼26–75% 
necrotic), 3 = severe (>75% necrotic). 
Distal colon gene expression 
Quantitative real-time polymerase chain reaction (qRT-PCR) of colon tissue was used to 
assess changes in gene expression. Approximately 30 mg of distal colon tissue was homogenized, 
subjected to RNA extraction using a modified RNeasy mini kit protocol (QIAGEN, Valencia, CA) 
with the addition of DNase, and stored at −80°C. Complementary DNA was synthesized using the 
reverse transcription reaction utilizing commercial first strand kits (Life Technologies Co. 
[Applied Biosystems], Carlsbad, CA) and random hexamer primers, as described in the 
manufacturer’s protocol. The RNA sample concentrations and purities were analyzed by a 
spectrophotometer, and RNA integrity was assessed by agarose gel electrophoresis (Labnet Gel 
XL Ultra V-2 Mini-Gel System; Labnet International, Inc. Edison, NJ). Expression of both pro-
inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-17A) and the anti-inflammatory cytokine, IL-10, 
were quantified as markers of an inflammatory response (primers: IL-1β, Mm00434228; TNF-α, 
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 Mm00443258; IL-6, Mm00446190; Mm00518984; IL-17A, Mm00439618; IL-10, 
Mm00439616). Additionally, expression of the chemokines CCL6 and CXCL1 (primers: CCL6, 
Mm01302419; CXCL1, Mm04207460) were quantified as markers of immune cell trafficking. 
Expression of free-fatty acid receptor 2 (FFAR2) (primer: Mm02620654) was evaluated as a 
potential mechanism of associating SCFA concentrations and leukocyte recruitment. A qRT-PCR 
instrument (7900HT Fast Real-Time PCR system and SDS Enterprise Database; Life 
Technologies; Carlsbad, CA) was used to assess gene expression, and Taqman® gene expression 
q-PCR master mixes were used (Applied Biosystems, Carlsbad, CA) to perform the q-PCR 
reaction. Expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an 
internal control (Su et al., 2007). Target genes were expressed relative to GAPDH using the ΔΔ-
Ct method as fold change, with the Cell/distilled treatment combination serving as the calibrator 
group (Livak and Schmittgen, 2001).  
Plasma serum amyloid A 
Concentrations of the acute phase protein, serum amyloid A (SAA) were measured in 
plasma by ELISA (Alpco Diagnostics, Salem, NH) as an indicator of systemic inflammation.  
Statistical analysis 
Differences from baseline in daily body weight, as well as fluid and water intake, were 
analyzed by 3-way ANOVA, with time as the repeated measure, to determine the combined effects 
of diet and water treatment combinations. Significant differences between diet and water 
treatments were set at P < 0.05 within each day. A significant interactive effect was set at P < 0.10 
for colon and cecal content measures. Gene expression, plasma SAA, and histology data were 
subjected to 2-way ANOVA at a single time-point (i.e., study conclusion). All data were analyzed 
using the MIXED procedure of SAS (SAS Inst. Inc., Cary, NC), and the UNIVARIATE procedure 
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 was used to identify outliers and ensure equal variance and normal distribution within the complete 
dataset. Data were transformed by log or square root if the assumption of equal variances was not 
met. Any observations more than 3 standard deviations from the mean were considered as outliers 
and removed.  
Results 
Body weight loss, as well as food and water intake, were measured from the beginning of 
DSS induction to study conclusion (Figure 4.1A-C). There were no significant differences in body 
weight between dietary treatment groups before beginning water treatments (24.47 ± 0.38 g and 
24.36 ± 0.38 g for Cell and PF, respectively). Throughout the 8-d water treatment period, 
consumption of DSS decrease (P < 0.05) BW of mice compared with the distilled water treatment. 
Mice on the Cell/DSS treatment showed an earlier (P < 0.05) decrease in BW starting at d 4 post-
DSS, whereas PF/DSS treatment started at d 5 post-DSS. A diet by DSS interaction (P < 0.05) 
was observed both on d 5 and d 8 post-DSS induction. At study end, PF-fed mice had lost less (P 
< 0.05) BW compared with Cell-fed mice. Assessments of behavioral changes and fecal pellet 
consistency in response to DSS were recorded, but no significant changes were noted (data not 
shown).  
Compared with mice provided distilled water, the Cell/DSS treatment combination resulted 
in decreased (P < 0.05) water intake on d 2, and d 4-8 post-DSS induction. Decreases (P < 0.05) 
in water intake did not begin until d 5 post-DSS in mice provided the PF/DSS treatment. Similarly, 
the Cell/DSS treatment elicited decreased (P < 0.05) food intake compared with distilled water 
mice on days 4-8 post DSS, whereas PF/DSS showed a decrease (P < 0.05) in food intake of even 
greater magnitude on d 5 and 6 post-DSS compared with healthy mice. Both the PF/DSS and 
Cell/DSS treatment groups, however, did regain similar food and water intakes by study end.   
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 Colon length and cecal weight (including contents) were measured to assess magnitude of 
DSS-induced sickness symptoms and extent of fermentation, respectively (Figures 4.2A-B). Colon 
length and cecal weights were lower (P < 0.05) in DSS-treated mice compared with mice receiving 
distilled water. Moreover, cecal weight was increased (P < 0.05) in PF-fed mice compared with 
Cell-fed mice. No interactive effects were noted for these outcomes. Concentrations of SAA were 
measured in plasma as an indication of systemic inflammation (Figure 4.3). Mice provided DSS 
had higher (P < 0.05) concentrations of SAA compared to mice provided distilled water, and no 
interactive effect was noted. 
Cecal contents were analyzed for SCFA concentrations to assess the magnitude and profile 
of fermentation end-product formation (Figure 4.4A-D). Concentrations of SCFA exhibited 
interactive effects (P < 0.10) and, in particular, cecal acetate, butyrate, and total SCFA. Mice fed 
the PF/DSS treatment had increased (P < 0.05) cecal acetate, butyrate, and total SCFA (P < 0.10) 
compared with mice on the Cell/DSS treatment. There was a negative effect on cecal fermentation 
with the DSS treatment, with PF-fed mice receiving distilled water having higher (P < 0.05) 
concentrations of acetate, butyrate, and total SCFA in cecal contents compared with PF-fed mice 
receiving DSS, but no differences between water treatments for mice fed Cell. Propionate 
concentrations in cecal contents did not show an interactive effect (P = 0.41); however, there was 
a significant main effect (P < 0.05) of dietary treatment, where mice fed PF had higher (P < 0.05) 
propionate concentrations in cecal contents compared with Cell-fed mice.  
Histology of distal colon was scored by independent, blinded observer to assess symptoms 
of DSS colitis (Figures 4.5A-C). Specifically, percent necrosis and inflammatory cell infiltration 
of innate immune cells were assessed. Both cellular infiltration and necrosis scores resulted in a 
main effect (P < 0.05) of water treatment, with mice receiving DSS having higher (P < 0.05) 
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 values compared with mice receiving distilled water. A diet by DSS interaction (P < 0.05) resulted 
in the assessment of infiltration of leukocytes into the lamina propria, with mice on the PF/DSS 
treatment having lower (P < 0.05) scores for infiltration of leukocytes compared with the Cell/DSS 
mice. Infiltration of leukocytes were not statistically different between dietary treatments in mice 
provided distilled water. Necrosis scores were higher (P < 0.05) in DSS-treated vs. control mice, 
with no interactive effects noted.  
Colon gene expression of pro-and anti-inflammatory cytokines (Figures 4.6A-E) and 
chemokines (Figures 4.7A-B) were analyzed as indications of inflammation and leukocyte 
recruitment, respectively. In general, DSS resulted in greater (P < 0.05) expression of pro-
inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-17A) compared with distilled water. Dietary 
PF blunted the inflammatory response induced by DSS, thereby producing lower (P < 0.05) 
colonic mRNA expression of TNF-α, IL-1β, IL-6, and IL-17A compared with Cell. A significant 
(P < 0.05) diet by DSS treatment interaction was observed with CXCL1 expression. Specifically, 
mice in the PF/DSS group having lower (P < 0.05) expression of CXCL1 compared with the 
Cell/DSS group. These changes were observed between diets in CXCL1 expression in mice 
provided distilled water. Expression of CCL6 showed no significant differences between dietary 
treatments (P = 0.27); however, an effect of DSS approached significance (P = 0.06) in the 
expression of CCL6 compared with the distilled water treatment. Free-fatty acid receptor 2 
(FFAR2) mRNA expression was also quantified as a potential mechanism linking leukocyte 
recruitment and SCFA concentrations (Figure 4.8). A main effect of water treatment was observed, 
with FFAR2 expression in DSS-treatment mice exhibiting higher (P < 0.01) expression compared 
with mice receiving distilled water. However, no diet by DSS treatment interaction was observed 
for FFAR2 expression (P = 0.36).  
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 Discussion 
Our main objective in this experiment was to determine if a moderately fermentable dietary 
fiber could attenuate the acute-inflammatory response compared with a non-fermentable fiber 
source (i.e., cellulose). Therefore, we formulated these diets to be isofibrous to ensure that 
experimental focus is strictly on fermentability. In terms inducing an acute-inflammatory response, 
it has previously been determined that DSS administered at 2-5% for a duration of 4-9 days is the 
best model for acute inflammation (Perše and Cerar, 2012). Observations of C57bl mice provided 
a 5% DSS solution however, have become too diseased (Melgar et al., 2005). Cook et al. (2013), 
found that a concentration of 2% for a duration of 5 days induced a peak acute inflammatory 
response at day 8 post DSS induction with low amounts of mortality. Therefore, we used this 
concentration for the same duration to induce a peak acute-inflammatory response at day 8 post 
induction. 
Previous chemical analysis of PF used in this study confirmed that it contains 55% TDF 
with 33% insoluble fiber and 22% soluble fiber. It also contains 30% starch, with 4.6% of this 
fraction as resistant starch, and has low concentrations of fat (2%) and crude protein (4.8%) 
(Panasevich et al., 2013). The Cell used in this study is a highly purified wood cellulose that is 
100% TDF and non-fermentable. Our diets were formulated to contain 8% TDF, due to previous 
results in dogs showing increases in fecal SCFA concentrations up to 6% addition into the diet 
(Panasevich et al., 2013). Therefore, PF was added at 14.5% of the diet, while Cell was added at 
8% to achieve equal fiber concentrations between diets.  
Dietary PF modulated the dog fecal microbiome in such a manner to suggest anti-
inflammatory effects as related to findings in IBD patients (Panasevich et al., 2015). In particular, 
ingestion of PF increased a known butyrate producer, Faecalibacterium (Faecalibacterium 
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 prausnitzii), which is a bacterial species often negatively associated with IBD in both dogs and 
humans (Suchodolski et al., 2012; Sokol et al., 2008; Ramirez-Farias et al., 2009). These results, 
however, were in healthy adult dogs and remained mere associations. Therefore, we sought to test 
the efficacy of PF in attenuating the inflammatory response in an experimentally-induced colitis 
model. We hypothesized that ingestion of PF would attenuate the symptoms of DSS-colitis by 
modulating the inflammatory response through the concentrations of SCFA (acetate, propionate, 
and butyrate) by fermentation of PF in the cecum of mice. 
Dietary fermentable fibers have previously been tested for their efficacy in attenuating the 
inflammatory response in DSS-colitis. Many of these studies, however, tested these fiber sources 
using diets that were unequal in dietary fiber, or where cellulose was supplemented to achieve 
equal dietary fiber concentrations (Moreau et al., 2003; Komiyama et al., 2011; Zarepor et al., 
2014). Our study aimed to use the DSS-mouse model to specifically study fermentable vs. non-
fermentable dietary fiber when diets were iso-fibrous. In humans, inflammatory bowel disease 
encompasses both ulcerative colitis and Crohn’s disease, which together affect more than 3.6 
million people in the United States and Europe (Kostic et al., 2014; Loftus, 2004). These diseases 
display symptoms of intermittent bouts of colonic and systemic inflammation (i.e., increases in 
pro-inflammatory cytokines and chemokines), diarrhea, abdominal pain, and increased rectal 
bleeding. Pharmaceutical agents such as antibiotics and immunosuppressants often are used in 
symptomatic treatment of IBD, but these remedies can be expensive and often have severe side-
effects. The efficacy of dietary fibers in suppressing an inflammatory response is dependent on the 
fermentation profile of the fiber (Rose et al., 2007). Therefore, an extensive evaluation of dietary 
fiber sources is needed in order to determine their efficacy in controlling such inflammatory 
diseases.  
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 Our indices of morbidity included food and water intakes, body weight loss, colon length, 
and cecum weight with contents. Fermentable fibers such as FOS and partially hydrolyzed guar 
gum have been found to decrease body weight loss in response to DSS (Goto et al., 2010; Naito et 
al., 2006). Compared with resistant starch, FOS was less beneficial in delaying body weight loss 
during DSS (Moreau et al., 2003). The GI tract and, in particular, the colon, has been found to 
become more fibrotic and will ultimately decreases in length in response to DSS (Diaz-Granados 
et al., 2000). Colon length has previously been found to be an accurate indicator of disease activity 
(Diaz-Granados et al., 2000). Furthermore, cecum weight with contents provides an idea of DSS 
symptoms, as well as an indirect measure of the extent of fermentability. Our results suggest that 
fermentable fiber intake did not have an effect on DSS-induced reduction in colon length; however, 
fermentation of PF in the cecum occurred during DSS-colitis. In general, PF-fed mice exhibited 
higher cecal weights, which translates to more fermentation in both control and DSS-treated mice, 
and lessening of symptoms in the PF/DSS treatment group.  
Previous studies investigating the effects of dietary fiber on attenuating the symptoms of 
chemically-induced acute colitis in animal models have provided contradictory findings. This 
could be explained by the differences in physicochemical properties of the fiber and, ultimately, 
their fermentability. For instance, highly fermentable fibers such as fructooligosaccharides (FOS) 
have been found to be protective against DSS-colitis when orally gavaged (Winkler et al., 2007; 
Goto et al., 2010); however, supplementation in a purified diet (i.e., cellulose as the only fiber 
source) showed no beneficial effects (Goto et al., 2010). Consumption of resistant starch, which is 
a more butyrogenic and moderately fermentable than FOS, with red meat was found to exert 
beneficial effects compared with consumption of red meat alone in an acute-colitis model (Le Leu 
et al., 2013). Furthermore, resistant starch, but not FOS, reduced macroscopic colonic cecal 
97 
 
 damage in a DSS model (Moreau et al., 2003). Other non-digestible carbohydrates such as goat 
milk oligosaccharides, lactulose, and lactulose-derived synthetic and natural milk saccharides also 
have been shown to reduce macroscopic damage in DSS-colitis animal models (Lara-Villoslada et 
al., 2006; Boehm and Stahl, 2007). Moreover, plant-derived oligosaccharides, such as hydrolyzed 
guar gum, enzymatically-treated rice fiber, cellulose, and germinated barley foodstuff, have been 
found to be beneficial in the DSS-colitis model by either ameliorating the symptoms (body weight 
or colon tissue integrity)  or eliciting lower expression of inflammatory markers (Naito et al., 2006; 
Komiyama et al., 2011; Nishimura et al., 2010; Kanauchi et al., 2001). Overall, we believe our 
results are consistent with those testing other moderately fermentable fibers in an acute DSS-colitis 
model. 
The duration and concentration of DSS administration used in this study were intended to 
initiate an acute-inflammatory response. The predominant innate immune cell types recruited in 
this type of colitis include neutrophils, monocytes, eosinophils, and dendritic cells. Chemokines 
are highly expressed in the colon of patients with IBD, and are known to direct immune cell 
trafficking, and exert anti-microbial effects (Kotarsky et al., 2010; Coelho et al., 2007). Here we 
measured both CCL6, a chemotactic agent for innate immune effector cells such as dendritic cells 
and macrophages, and CXCL1, a neutrophil chemoattractant (Coelho et al., 2007; Puleston et al., 
2005). Although expression of CCL6 was not affected by dietary treatment, there was a strong 
trend for a water main effect. This suggests that DSS caused detrimental colonic epithelial barrier 
function, thereby potentially allowing bacterial translocation from the intestinal lumen (Kotarsky 
et al., 2010). What was particularly interesting were the changes in CXCL1 distal colon gene 
expression. Mice treated with DSS and provided with dietary Cell, a non-fermentable fiber, had a 
7-fold increase in CXCL1 expression compared with DSS-treated mice receiving PF. In this acute-
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 colitis model, neutrophils would be the predominant innate immune cell type at the site of 
inflammation.  
We hypothesized that a moderately fermentable fiber would attenuate the acute-
inflammatory response in DSS-colitis more effectively than cellulose, an inert non-fermentable 
fiber. Therefore, we analyzed cecal SCFA concentrations as an indication of fermentation, thereby 
providing quantitative evidence of the protective effects PF may provide against DSS-colitis. Even 
with induction of DSS-colitis, PF-fed mice had higher concentrations of acetate, butyrate, and total 
SCFA in cecal contents. In terms of fermentability and prebiotic potential, these results support 
our previous experiments investigating PF in vitro and in the dog (Panasevich et al., 2013; 
Panasevich et al., 2014). Previous studies testing prebiotic fibers in DSS-colitis rodent models 
have typically elicited anti-inflammatory effects. Ingestion of dietary fibers such as rice bran, 
resistant starch, and hydrolyzed plant polysaccharide were found to reduce mucosal damage and 
had anti-inflammatory properties (Komiyama et al., 2011; Moreau et al., 2003; Naito et al., 2006). 
Conversely, dietary flaxseed, which contains anti-inflammatory bioactive components such as 
fermentable fiber, phenolic compounds, and the polyunsaturated fatty acid, α-linolenic acid, was 
found to exacerbate colonic damage and inflammatory cytokines, even with increases in cecal 
SCFA concentrations (Zarepor et al., 2014). Consumption of highly fermentable FOS also 
produced mixed results in reducing DSS-induced colonic damage (Winkler et al., 2007; Goto et 
al., 2010). A study investigating fiber-enriched vs. low-fiber germinated barley in DSS-colitis 
suggested the fiber component was anti-inflammatory (Kanauchi et al., 2001). Collectively, these 
studies suggest that moderately fermentable and butyrogenic dietary fibers are the most effective 
at attenuating DSS-colitis.  
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 Our histopathological analysis and distal colon gene expression of pro-inflammatory 
cytokines (TNF-α, IL-1β, IL-6, and IL-17a) support our hypothesis of SCFA-induced anti-
inflammation during DSS. Dietary PF exhibited decreases in leukocyte infiltration scores in distal 
colon compared to Cell. Furthermore, mice on the PF/DSS treatment reduced distal colon 
inflammation by exhibiting decreases in TNF-α, IL-1β, IL-6, and IL-17a compared to the Cell/DSS 
group. Taken together, the cecal SCFA concentrations, infiltration of leukocyte pathology scores, 
and pro-inflammatory cytokine gene expression, indicate an association of SCFA affecting 
leukocyte recruitment during DSS-induced colitis.  
The low viability of leukocytes and, in particular, neutrophils, make them very difficult to 
study them in tissues. We measured degree of leukocyte infiltration using a previously validated 
scoring system to look at the degree of total leukocyte recruitment (Wirtz et al., 2007). One 
proposed mechanism for SCFA to affect the innate immune response is through taste-receptors 
present on the cell surface of leukocytes and, more specifically, neutrophils (Vinolo et al., 2009; 
Maslowski et al., 2009). Indeed, butyrate is considered to be the most beneficial SCFA in terms of 
gut health, as it is known to down-regulate nuclear factor-beta (NF-κB), a master regulatory switch 
closely involved in inflammatory processes, and increase peroxisome proliferator-activated 
receptor gamma, to ultimately reduce paracellular permeability of colonic epithelial cells (Segain 
et al., 2000; Russo et al., 2012; Kinoshita et al., 2002). Butyrate also is considered the primary 
energy source for colonic epithelial cells (Topping and Clifton, 2001). More recently, however, 
there has been interest in the role of SCFA (in particular, acetate) in controlling leukocyte 
recruitment (mainly neutrophils) to the site of inflammation via the taste receptor free fatty-acid 
receptors (FFAR) 2 and 3.  
100 
 
 Prevailing hypotheses suggest SCFA produced by the colonic microbiota could control 
leukocyte recruitment by two main mechanisms: (1) activation of FFAR 2 and 3, and (2) inhibition 
of histone deacetylase (Vinolo et al., 2009). Neutrophil recruitment to the site of inflammation has 
been of recent interest in terms of controlling the inflammatory response. Short-chain fatty acids 
have been found to bind members of the FFAR2 family, which are highly expressed on neutrophils, 
monocytes, adipocytes, and on enterendocrine cells in the GI tract (Vinolo et al., 2009; Nøhr et al., 
2013). Since SCFA are binding agonists for FFAR2, they serve to activate several intracellular 
pathways such as protein kinase C, mitogen-activated protein kinases, and other transcriptional 
factors involved with the chemotactic movement of neutrophils (Vinolo et al., 2009). Although 
SCFA are a chemoattractant for neutrophils in vitro, there are limited studies that investigate the 
implications of this in vivo where there are other FFAR2 binding agonists (e.g., formyl-
methionine-leucine-phenylalanine, chemokines, and leukotriene B4) (Vinolo et al., 2009).  
Recent evidence from a DSS-induced colitis model involving FFAR2-knockout mice 
suggested that ingestion of solubilized acetate in the presence of colonic microbiota ameliorated 
the acute inflammatory response (Maslowski et al., 2009). Furthermore, the ingestion of SCFA 
also had a systemic effect on inflammation by reducing inflammation in mice with asthma 
(Maslowski et al., 2009). The in vitro and in vivo studies clearly show an effect of SCFA on 
mounting a neutrophil chemotactic response; however, these results are contingent on ingestion of 
SCFA, not on intake of dietary fermentable fiber. We measured distal colon gene expression of 
FFAR2 as a possible involvement of SCFA in controlling leukocyte recruitment. While there was 
no interactive effect of diet and water treatments, mice induced with DSS-colitis exhibited higher 
expression of FFAR2 in distal colon, which supports the notion that FFAR2 has a role in the 
inflammatory response initiated by chemically-induced colitis. 
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 An alternative explanation for the immune response seen here is the bridge between the 
adaptive and innate immune systems through changes in IL-17a expression. During DSS-induced 
colitis, mice ingesting PF exhibited IL-17a expression levels comparable to mice given distilled 
water. Ingestion of non-fermentable Cell during DSS exhibited a 40-fold increase in expression of 
IL-17a relative to mice fed PF.  Specialized T-cells, called T-helper 17 (Th17) cells, are considered 
a major source of IL-17a, which attracts neutrophils (Jin and Dong, 2013). Recently, there has 
been interest in a T-cell subtype (i.e., innate-Th17 cells) that reside in the lamina propria of the 
intestine. Enteric bacteria such as Citrobacter rodentium and Salmonella typhimurium have been 
shown to activate resident Th17 cells and, ultimately, produce IL-17 in cecal tissue (Jin and Dong, 
2013). Other innate immune cell types produce IL-17 as well, including lymphoid tissue induced 
cells, natural killer and natural killer T cells, macrophages, and Paneth cells (Reynolds et al. 2010; 
Cua et al., 2010). Furthermore, IL-17a signal transduction mediates NF-κB and MAPK pathways 
that ultimately lead to the concentrations of pro-inflammatory cytokines, chemokines, and 
eventually myeloid cell recruitment to the site of inflammation (Shalom-Barak et al. 1998; Awane 
et al. 1999). Recently, SCFA have been found to induce both effector and regulatory T cells by 
suppression of histone deacetylases in a manner independent of both FFAR2 and 3 (Park et al., 
2015). Inhibition of histone deacetylases by SCFA and, in particular, acetate, has been shown to 
regulate the mTOR pathway required for the generation of Th17 cells (Park et al., 2015).  
Inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis are 
autoimmune disorders marked by flares of uncontrolled inflammation, and non-pharmaceutical 
remedies to control this inflammation are desperately needed. Overall, our present study, taken 
together with previous investigations of dietary PF in vitro and in the dog, strongly suggest that 
PF is a prebiotic fiber that has anti-inflammatory properties in an acute-colitis model. Results of 
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 this study confirm that ingestion of moderately fermentable PF is protective against weight loss 
and pro-inflammatory cytokines induced by DSS-colitis compared with non-fermentable cellulose. 
Furthermore, ingestion of PF elicited decreases in leukocyte recruitment pathological scores in the 
distal colon of DSS-treated mice. Our data associate concentrations of SCFA in leukocyte 
recruitment, as indicated by changes in chemokine expression (CXCL1). This response, however, 
may be due to decreasing induction of effector and regulatory T-cells and, in particular, innate 
Th17 cells independent of FFAR2 as indicated by changes in expression of IL-17a.  
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Figure 4.1. Effects of DSS on body weight (A), water intake (B), and food intake (C). PF; 
potato fiber; DSS; dextran sodium sulfate. All values are expressed relative to baseline, 
which was the percentage of the body weight, food and water intakes on the day of DSS 
induction. *Signifies a difference (P < 0.05) within day between dietary treatments for mice 
receiving DSS.  Cellulose/distilled (n=17); potato fiber/ distilled (n=16); cellulose/DSS 
(n=17); potato fiber/DSS (n=17).
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Figure 4.2. Effects of DSS on colon length (A) and cecum weight with contents (B). Both 
colon length and cecum weights with contents are represented relative to total BW on d 8 
post-DSS (i.e., study conclusion). Cellulose/distilled (n=17); potato fiber/distilled (n=15); 
cellulose/DSS (n=17); potato fiber/DSS (n=17). 
 
 
 
 
 
 
 
110 
 
  
Plasma serum amyloid A
Distilled DSS
0
500
1000
1500
Diet P = 0.41
DSS P < 0.01
Diet × DSS P = 0.54
Cellulose
Potato fiber
Water treatment
µ
g/
m
l
 
 
Figure 4.3. Effects of DSS on plasma concentrations of serum amyloid A. Cellulose/distilled 
(n=8); potato fiber/ distilled (n=8); cellulose/DSS (n=6); potato fiber/DSS (n=8). 
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Figure 4.4. Effects of DSS on cecal concentrations of acetate (A), propionate, (B), butyrate (C), and total short-chain fatty acids (SCFA) (D) 
when mice were fed a cellulose or potato fiber diet. Different letters denote differences (P < 0.05) between treatment groups (cellulose/distilled 
(n=17); potato fiber/distilled (n=16); cellulose/DSS (n=9); potato fiber/DSS (n=14)). All SCFA concentrations are represented as micromoles 
per gram of cecal content on a dry matter basis.  
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Figure 4.5. Effects of PF on visual differences in leukocyte infiltration and edema (A). Red arrows represent areas of leukocyte (mainly 
neutrophils) accumulation in the lamina propria. Histology scores were based of a previously validated scoring system (Wirtz et al., 2007) for 
infiltration of leukocytes (B) and percent necrosis (C) are presented for all treatments. Cellulose/distilled (n=9); potato fiber/ distilled (n=8); 
cellulose/DSS (n=10); potato fiber/DSS (n=9). Different letters represent differences (P < 0.05) between treatment groups.  
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Figure 4.6. Effects of DSS on distal colon gene expression of pro-inflammatory cytokines (n=10-12 per group) (TNF-α, IL-1β, IL-6, and IL-
17A) (A-D, respectively) and anti-inflammatory cytokine IL-10 (E) in both cellulose (Cell)-and potato fiber (PF)-containing diets. All gene 
expression is represented as fold change in ΔΔ-Ct values relative to the cellulose/distilled treatment group. Different letters represent differences 
(P < 0.05) between treatment groups.  
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Figure 4.7. Effects of DSS on distal colon gene expression of the chemokines CXCL1 (n=12 per 
group) (A) and CCL6 (n=11-12 per group) (B) when mice were fed either cellulose or potato 
fiber diets. All gene expression is represented as fold change in ΔΔ-Ct values from the 
cellulose/distilled treatment group. Different letters represent differences (P < 0.05) between 
treatment groups.  
115 
 
 FFAR2
Distilled DSS
0
1
2
3
4
5
Diet P = 0.61
DSS P < 0.01
Diet × DSS P = 0.36Cellulose
Potato fiber
Water treatment
Fo
ld
 c
ha
ng
e
Figure 4.8. Effects of DSS on distal colon gene expression of free fatty acid receptor 2 (FFAR2) 
when mice were fed either cellulose or potato fiber diets. All gene expression is represented as 
fold change in ΔΔ-Ct values from the cellulose/distilled treatment group. Cellulose/distilled 
(n=11); potato fiber/ distilled (n=11); cellulose/DSS (n=12); potato fiber/DSS (n=12) 
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 CHAPTER 5: FUTURE DIRECTIONS 
 The collection of studies presented in this thesis display how changes in the fecal 
microbiome through ingestion of dietary fiber in healthy dogs were associated with health and 
disease. In particular, PF ingestion modulated the fecal microbiome in dogs that was suggestive of 
anti-inflammatory effects. Therefore, we designed a study to evaluate the efficacy of PF in 
attenuating the inflammatory response in an acute-colitis mouse model. This study revealed that a 
PF-containing diet was more anti-inflammatory than the Cell diet in DSS colitis. We investigated 
this further by showing associations with SCFA concentrations and leukocyte recruitment. 
Specifically, we made an association with DSS and FFAR2, which is found on enteroendocrine 
cells and leukocytes in the lamina propria of colon (Nøhr et al., 2013). This association was also 
made with innate Th17 cells that reside in the lamina propria. Therefore, future studies are needed 
to investigate the mechanism of how SCFA production influences immune cell recruitment and 
thereby alters inflammatory processes.  
 Utilizing a genetic knockout mouse would be most effective in studying the role FFAR2 
in relation to dietary fiber intake and inflammation. Specifically, an FFAR2 knockout mouse 
provided either a PF or Cell diet in response to DSS colitis would help to elucidate a mechanism 
for how SCFA may control leukocyte recruitment in the distal colon. Previous in vivo studies have 
investigated how ingestion of SCFA could affect the inflammatory response in an FFAR2-
dependent manner; however, this has not been related back to the ingestion of specific dietary 
fibers (Maslowski et al., 2011; Vinolo et al., 2011). It is advisable to investigate how a fermentable 
vs. non-fermentable diet would impact leukocyte recruitment and, in particular, neutrophil 
recruitment in a FFAR2 knockout given DSS colitis. Our previous study utilized a hematoxylin 
and eosin stain on distal colon tissue to assess leukocyte recruitment by an independent observer. 
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 In order to specifically link SCFA concentrations and neutrophil recruitment, one could utilize 
immunohistochemistry (IHC) of the distal colon tissue incubated with the primary antibodies 
Ly6G and p38. It has been previously shown that phosphorylation of p38 MAPK lessens the 
chemotactic response of neutrophils (Sina et al., 2009). Assessment of distal colon by IHC with 
these primary antibodies would assess: (1) a link between SCFA concentrations and neutrophil 
recruitment, and (2) changes in the chemotactic response of neutrophils in response to fermentable 
fiber intake. We hypothesize that dietary PF would decrease neutrophil recruitment and increase 
phosphorylation of p38 MAPK intracellular pathway in colon-derived neutrophils. 
One other future direction of this work would be to investigate different immune cell 
phenotypes in response to fermentable fiber intake. More specifically, looking at immune cells 
involved in the adaptive immune response. The DSS model is effective at investigating the role of 
the innate immune response; however, the major limitation of this model is that it does not require 
a T or B cell response (Chassing et al., 2014). Therefore, the more appropriate model to investigate 
the adaptive immune response would be utilizing the IL-10 knockout model. We would use the 
same diets in order to evaluate fermentable fiber’s influence on attenuating the inflammatory 
response in this model. Immunofluorescence (IF), IHC, or flow cytometry would be appropriate 
in quantifying different immune cell types. We observed a robust response in mRNA expression 
of IL17a in distal colon tissue in Chapter 4 of this thesis, and we associated this effect with innate 
Th17 cells. Therefore, interest in evaluating these cells in distal colon by IF using primary 
antibodies for IL17 and CD4 may be useful in evaluating their role in this type of colitis (Zhang et 
al., 2013).   
Overall, our combination of studies revealed associations between fermentable fiber intake 
and leukocyte recruitment. In order to evaluate the exact mechanism that shows a direct link 
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 between SCFA and leukocyte recruitment and activation, more studies utilizing genetic knockout 
mice and different techniques, such as IF, IHC, and flow cytometry, are needed. These current 
studies are a pivotal step in showing the immunomodulatory effects of dietary fiber on colonic 
inflammation. In conclusion, more studies are needed to investigate the mechanisms of how 
fermentation of dietary fiber impacts different immune cell types to be recruited to the site of 
inflammation.  
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